2016 Annual Meeting | Poster Session 5 (standby time 5:30 pm

2016 Annual Meeting | Poster Session 5 (standby time 5:30 pm - 7:00 pm)

Date Wednesday 04/20/16

Time 08:30 AM - 07:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology, Neuroepidemiology

CME Available 0.00 credit

Event Timeline
08:30 AM - 07:00 PM	Abstract	001 - Evaluation of Mitochondrial Function in CHCHD10 Mutation Jianhua Yan, PhD
08:30 AM - 07:00 PM	Abstract	002 - Ataluren Confirmatory Trial in DMD: Effect of Ataluren on Activities of Daily Living in Nonsense Mutation Duchenne Muscular Dystrophy
08:30 AM - 07:00 PM	Abstract	003 - Adaptive Design Single Center Phosphodiesterase Type 4 (PDE4) Inhibitor - Ibudilast (MN-166-ALS-1201) Phase 1b/2a Clinical Trial Double-Blind (DB) with Open Label Extensions (OLE) [ NCT02238626 ] for Amyotrophic Lateral Sclerosis (ALS) Patients [1] Not Requiring Non-Invasive Ventilation (no-NIV) up to 5 Years (Early Cohort-EC) and [2] Requiring Non-Invasive Ventilation (NIV) up to 10 Years(Advanced NIV Cohort-ANC) from Disease Onset - Behavior of Creatinine as a Biomarker in Short Clinical Trials Benjamin R. Brooks, MD, FAAN
08:30 AM - 07:00 PM	Abstract	004 - Interim Results of a Phase 2 Clinical Study of Nusinersen (ISIS-SMNRx) in Patients with Infantile-Onset Spinal Muscular Atrophy Richard S. Finkel, MD, FAAN
08:30 AM - 07:00 PM	Abstract	005 - A Comparison of the Effects of Deflazacort and Prednisone Versus Placebo on Timed Functional Tests in Boys with Duchenne Muscular Dystrophy James M. Meyer, PharmD
08:30 AM - 07:00 PM	Abstract	006 - Should Motor Function Determine the Timing of Scoliosis Surgery in Spinal Muscular Atrophy (SMA)? Sally Dunaway, DPT
08:30 AM - 07:00 PM	Abstract	007 - Electrical Impedence Myography Correlates to Muscle Pathology on MRI and in Muscle Biopsies in Facioscapulohumeral Muscular Dystrophy Type 1 Melanie Glenn, MD
08:30 AM - 07:00 PM	Abstract	008 - Hu Antigen R Is a Positive Regulator of ALS-Associated RNA Binding Proteins TDP-43 and FUS Liang Lu, MD, FAAN
08:30 AM - 07:00 PM	Abstract	009 - Comparing Anti-Epileptic Drug Preferences Between Neurologists and Patients: Results from a National Survey and Discrete Choice Experiment Alan Ettinger, MD, FAAN
08:30 AM - 07:00 PM	Abstract	010 - rTMS Induces Changes in FDG Brain Metabolism in Patients with Epilepsy Laura M. Seynaeve, MD
08:30 AM - 07:00 PM	Abstract	011 - Validating StatNet EEG as a Reliable and Effective Tool in the Diagnosis of Non-Convulsive Status Epilepticus: Phase 2 Alexandra Carter, MD
08:30 AM - 07:00 PM	Abstract	012 - Status Epilepticus in Patients with SMART Pei'En Fan, MD
08:30 AM - 07:00 PM	Abstract	013 - Response to IVIG in Patients with CIDP: The INSIGHTS Quality Improvement Registry Todd D. Levine, MD
08:30 AM - 07:00 PM	Abstract	014 - Ultrasound Is a Sensitive Technique to Detect Fasciculations of Cranial Muscles in Amyotrophic Lateral Sclerosis (ALS) Cullen M. O'Gorman, MBBS
08:30 AM - 07:00 PM	Abstract	015 - Structural Brain MRI Abnormalities in Kennedy's Disease Pilar Maria Ferraro, PhD
08:30 AM - 07:00 PM	Abstract	016 - The Novel m.9997 T>A tRNAGly Variant Causes Multisystem Mitochondrial Disease Including Myopathy, Neuropathy, Cardiomyopathy, Intestinopathy and Nephropathy Jennifer A. Roggenbuck, MS, CGC
08:30 AM - 07:00 PM	Abstract	017 - Persistent Intraoperative Neurophysiologic Monitoring Changes in Scoliosis Surgery Correlate with Postoperative Deficits Viet Nguyen, MD
08:30 AM - 07:00 PM	Abstract	019 - Genotype-Phenotype Relationships in Peripheral Neuropathies: Challenging the ‘Status Quo’ Tracy Brandt, PhD
08:30 AM - 07:00 PM	Abstract	020 - Novel Intragenic Duplication of MFN2 Gene Cause CMT2A with Considerable Phenotypic Variability Gyula Acsadi, MD, FAAN
08:30 AM - 07:00 PM	Abstract	021 - Neuropathy Associated HSPB1 Mutations Result in Loss of Neuroprotection in an In Vitro Model of Astrocyte Toxicity to Motor Neurons
08:30 AM - 07:00 PM	Abstract	022 - Variants in Four Genes on Chromosome 12 Is Associated with Intermediate Charcot-Marie-Tooth Disease Geir Braathen
08:30 AM - 07:00 PM	Abstract	023 - Clinical and Genetic Assessment in Korean Patients with Congenital Insensitivity to Pain with Anhidrosis Tai-Seung Nam, MD
08:30 AM - 07:00 PM	Abstract	024 - Clinical and Genetic Heterogeneity in Charcot-Marie-Tooth Neuropathy Type 2 Patients from Turkey Hacer Durmus, MD
08:30 AM - 07:00 PM	Abstract	025 - Erythromelalgia: A Novel Mutation in SCN9A Causing Chronic Neuropathic Burning Feet Syndrome without Classic Skin Findings Jigar P. Mankad, MD
08:30 AM - 07:00 PM	Abstract	026 - Clinical and Mutation Analysis of GAP Junction Beta 1 (GJB1) Gene in Brazilian Patients with the Diagnosis of X-Linked Type 1 Charcot-Marie-Tooth Disease (CMTX1) Eduardo B. Uchoa Cavalcanti, MD, PhD, MSc, FAAN
08:30 AM - 07:00 PM	Abstract	027 - A Novel CMT2P Missense Mutation in the RING Domain of LRSAM1 Impairs the Nuclear Transport of FUS
08:30 AM - 07:00 PM	Abstract	028 - Recurrent Episodes of Stroke-Like Symptoms in a Patient with Charcot-Marie-Tooth Neuropathy X Type 1 (CMTX1) Ning Wu, MD
08:30 AM - 07:00 PM	Abstract	029 - Severe Neuropathic Pain Syndrome, with Ulceromutilating Neuropathy and Spastic Paraparesis, Associated with the p.Ala354Pro Variant in ATL1 Neha Khade, MD
08:30 AM - 07:00 PM	Abstract	030 - Clinicopathological Features of Anti-NT5c1A Positive Patients in the Group of Myositis Patients with CD8-MHC-1 Complex Pathology Chiseko Ikenaga, MD, PhD
08:30 AM - 07:00 PM	Abstract	031 - NKG2D - IL-15 Signaling Is Critically Involved in the Pathogenesis of Inflammatory Myopathies Tobias Ruck
08:30 AM - 07:00 PM	Abstract	032 - Effect of Deflazacort and Prednisone on Muscle Enzymes in the Treatment of Duchenne Muscular Dystrophy Jordan S. Dubow, MD
08:30 AM - 07:00 PM	Abstract	033 - Post Insulin Receptor Signalling Abnormalities Contribute to Insulin Resistance in Myotonic Dystrophies Giovanni Meola, MD, FAAN
08:30 AM - 07:00 PM	Abstract	034 - The Compromised Fidelity of B Cell Tolerance Checkpoints Contributes to Autoimmunity in Myasthenia Gravis Panos-Alexis Stathopoulos, MD
08:30 AM - 07:00 PM	Abstract	035 - Predictive Value of Single-fiber EMG in Orbicularis Oculi Muscle to Treatment in Patients with Seronegative Ocular Myasthenia: A Series of Hundred Forty Two Patients Goran Rakocevic, MD, FAAN
08:30 AM - 07:00 PM	Abstract	036 - Measuring Clinical Efficacy of Azathioprine in Myasthenia Gravis with Mean Corpuscular Volume Ning S. Yang, MD
08:30 AM - 07:00 PM	Abstract	037 - Effect of Deflazacort and Prednisone Versus Placebo on Pulmonary Function in Boys with Duchenne Muscular Dystrophy Who Have Lost Ambulation Jordan S. Dubow, MD
08:30 AM - 07:00 PM	Abstract	038 - Should the Use of the Extended Myositis Antibody (EMA) Panel Be Part of the Routine Work-Up in Suspected Myositis?
08:30 AM - 07:00 PM	Abstract	039 - Biomarkers Reflect ALS Clinical Courses Siw Johannesen, MD
08:30 AM - 07:00 PM	Abstract	040 - Potential Immune Biomarkers for Disease Progression in ALS Weihua Zhao, MD
08:30 AM - 07:00 PM	Abstract	041 - Changes in Motor Unit Number Estimate and Forced Vital Capacity as Predictors of ALS Progression Nicholas T. Olney, MD
08:30 AM - 07:00 PM	Abstract	042 - Skeletal Muscle MicroRNAs 206 and 424 are Prognostic Markers in Amyotrophic Lateral Sclerosis (ALS)
08:30 AM - 07:00 PM	Abstract	043 - Retinal Degeneration Detectable by Optical Coherence Tomography as a Potential Biomarker for Amyotrophic Lateral Sclerosis
08:30 AM - 07:00 PM	Abstract	044 - Hemoglobin Levels Improve Following Switch from Intravenous to Subcutaneous Administration of Immunoglobulin in CIDP and MMN Ingelise Christiansen, PhD
08:30 AM - 07:00 PM	Abstract	045 - Biomarkers for Rapid Progression in Familial Amyloid Neuropathy Sung-Tsang Hsieh, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	046 - In-Vivo Reflectance Confocal Microscopy of Meissner’s Corpuscles as an Objective Measure of Diabetic Polyneuropathy Peter D. Creigh, MD
08:30 AM - 07:00 PM	Abstract	047 - Whole Exome Sequencing of Familial ALS and Trios of Sporadic ALS to Identify New Genes Associated with ALS
08:30 AM - 07:00 PM	Abstract	048 - Immunohistochemical Analysis of ErbB4 in the Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
08:30 AM - 07:00 PM	Abstract	049 - Genetic Background of the Hereditary Spastic Paraplegia Phenotypes in Hungary Maria J. Molnar, MD, PhD
08:30 AM - 07:00 PM	Abstract	050 - Results from a Multi-Gene NGS Panel for Hereditary Spastic Paraplegia
08:30 AM - 07:00 PM	Abstract	051 - Clinical and Neuropathological Study of an Autopsied Case of Familial ALS with SOD1 Mutation with Very Long Survival Yo-ichi Takei
08:30 AM - 07:00 PM	Abstract	052 - The Genetic Signature of Sex Chromosome-Related Mutations Expressing as a Neurodegenerative Disorders: Rarity, Randomness or Underestimation? Fernando Santos Pinheiro, MD
08:30 AM - 07:00 PM	Abstract	053 - Study of Intermediate-Length polyQ Repeats in Sporadic and Familial Amyotrophic Lateral Sclerosis Felix L. Nunez-Santana, PhD
08:30 AM - 07:00 PM	Abstract	054 - Clinical and Genetic Heterogeneity in Familial ALS Patients from Turkey Hacer Durmus, MD
08:30 AM - 07:00 PM	Abstract	055 - Comparison of the Diagnostic Yield of Comprehensive and Phenotypically Driven Multi-Gene Panels for Neuromuscular Disorders Amanda S. Lindy, PhD
08:30 AM - 07:00 PM	Abstract	056 - Atypical Electropherogram Patterns are Observed Among C9orf72 (G4C2) Expansion Carriers in a Familial and Sporadic ALS and ALS/FTD North American Cohort Study Jessica P. Lowry, PhD
08:30 AM - 07:00 PM	Abstract	057 - Characterization of Gait and Fatigue in Children and Adults with Spinal Muscular Atrophy Using Instrumented Footwear Jacqueline Montes, PT, EdD, NCS
08:30 AM - 07:00 PM	Abstract	058 - Striking Histologic Heterogeneity in Polyglucosan Body Myopathies Edoardo Malfatti, MD
08:30 AM - 07:00 PM	Abstract	059 - Potential Mechanisms for Prolonged Loss of Ambulation with Deflazacort in Duchenne Muscular Dystrophy - Tolerability Profile and Effects on Growth Timothy Cunniff, PharmD
08:30 AM - 07:00 PM	Abstract	060 - Isolated Triceps Myositis as an Initial Presentation of Pompe Disease Tyler Koehn, MD
08:30 AM - 07:00 PM	Abstract	061 - Beta Sarcoglycanopathy Caused by a New Mutation in a Palestinian Family Ricardo E. Madrid, MD, FAAN
08:30 AM - 07:00 PM	Abstract	062 - The Core Protein to Myogenesis NFAT5 Forms Aggresomes in Normal and Duchenne Muscular Dystrophy Myotubes Exposed to Cell Stressors Sandrine Herbelet, DVM
08:30 AM - 07:00 PM	Abstract	063 - Recognizing Congenital Myopathy in an Adult - A Case Report Carla M. Grosmann, MD
08:30 AM - 07:00 PM	Abstract	064 - Case of Recurrent, Severe Rhabdomyolysis with Chronic Pain and Dysphagia Cause by Novel Mutation in RYR1 Gene Jigar P. Mankad, MD
08:30 AM - 07:00 PM	Abstract	065 - Cardiac Conduction Defects in Oculopharyngeal Muscular Dystrophy Naganand Sripathi, MD
08:30 AM - 07:00 PM	Abstract	066 - Clinical and Molecular Features of Myotonic Dystrophy Type 1 in Peru
08:30 AM - 07:00 PM	Abstract	067 - A Premature Stop Codon in MYO18B Is Associated with Severe Nemaline Myopathy with Cardiomyopathy Edoardo Malfatti, MD
08:30 AM - 07:00 PM	Abstract	068 - Inherited Myopathies with Early Respiratory Involvement Elie Naddaf, MD
08:30 AM - 07:00 PM	Abstract	069 - Late Diagnosis of SEPN-1 Related Myopathy : Case-Series Report of Initially Unexplained Respiratory Insufficiency Fahad F. Albassam, MD
08:30 AM - 07:00 PM	Abstract	070 - Diagnostic Algorithm in Adult-Onset Mendelian PEO Associated with Mitochondrial Disease Grainne Gorman
08:30 AM - 07:00 PM	Abstract	071 - A Novel Intronic Mutation in TK2 Affects mRNA Expression and Causes Adult-Onset Mitochondrial Depletion Syndrome
08:30 AM - 07:00 PM	Abstract	072 - A Novel RRM1 p.381R>H Mutation Causing MNGIE-like Disease Marti Juanola-Falgarona, PhD
08:30 AM - 07:00 PM	Abstract	073 - Different Clinical Manifestations of MELAS in a Single Family Shiney Koshy, MD
08:30 AM - 07:00 PM	Abstract	074 - Hereditary Inclusion Body Myopathy without Paget Disease and Frontotemporal Dementia Associated with Valosin-Containing Protein Mutation: A Case Report Katrina M. Pack, MD
08:30 AM - 07:00 PM	Abstract	075 - Hereditary Spastic Paraplegia Type 4 (SPG4): A Clinico-Genetic Study in a Large Cohort of Patients with Spastic Paraplegia
08:30 AM - 07:00 PM	Abstract	076 - Ethnicity and Age of Patients Hospitalized with Myasthenia Gravis: Unique Demographics in Hawaii
08:30 AM - 07:00 PM	Abstract	077 - Causes and Predictors of Mortality in a Large U.S. Myotonic Dystrophy Type 1 Adult Cohort Julian C. Duda, MD
08:30 AM - 07:00 PM	Abstract	078 - Prevalence of Polyneuropathy in the General Population: The Rotterdam Study Rens Hanewinckel, MD, PhD
08:30 AM - 07:00 PM	Abstract	079 - Annual Hospital Admissions for Myasthenia Gravis in Hawai‘i Compared to Other States Keli Tahara, MD
08:30 AM - 07:00 PM	Abstract	081 - Abdominal Obesity is Related to Polyneuropathy, Irrespective of Diabetes: A Population-Based Analysis Rens Hanewinckel, MD, PhD
08:30 AM - 07:00 PM	Abstract	082 - Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy Molly Lamb, PhD
08:30 AM - 07:00 PM	Abstract	083 - Hospital Care for Mental Health and Substance Abuse in Pediatric Epilepsy Adys Mendizabal, MD, MS
08:30 AM - 07:00 PM	Abstract	084 - Obesity Is an Independent Predictor of Pediatric Hospitalizations for Epilepsy: Data from the Nationwide Emergency Department Sample (NEDS) Delaram Safarpour, MD, MSCE, FAAN
08:30 AM - 07:00 PM	Abstract	085 - A Retrospective Study to Identify Novel Prognostic Factors for Glioblastoma Patients Survival: Survival Outcomes Prognostication in Glioblastoma Diagnosed Patients Jad A. Dandashi
08:30 AM - 07:00 PM	Abstract	086 - Projected Number of Amyotrophic Lateral Sclerosis Cases from 2005 to 2030
08:30 AM - 07:00 PM	Abstract	087 - Amyotrophic Lateral Sclerosis Mortality in the United States, 2011-2013 Theodore Larson
08:30 AM - 07:00 PM	Abstract	088 - Earlier Disease Onset in Non-Caucasian Amyotrophic Lateral Sclerosis (ALS) Patients: Retrospective Analysis from Two Tertiary Centers Hristelina S. Ilieva, MD
08:30 AM - 07:00 PM	Abstract	089 - Pseudobulbar Affect (PBA) as a Predictor of Survival in ALS
08:30 AM - 07:00 PM	Abstract	090 - Rural Environment, Pesticide Exposure and the Risk of Amyotrophic Lateral Sclerosis: A Meta-Analysis of Observational Studies Dongchao Shen
08:30 AM - 07:00 PM	Abstract	091 - The Evaluation and Management of Alternative Diagnoses in Amyotrophic Lateral Sclerosis Meena R. Kannan, MD
08:30 AM - 07:00 PM	Abstract	092 - Time-Trend Evolution and Determinants of Sex Ratio in Amyotrophic Lateral Sclerosis Benoit Marin
08:30 AM - 07:00 PM	Abstract	093 - Novel Gender Selective Survival Effect of C9orf72 in European ALS Cohorts James P. Rooney
08:30 AM - 07:00 PM	Abstract	094 - National Amyotrophic Lateral Sclerosis (ALS) Biorepository Feasibility Study Wendy E. Kaye, PhD
08:30 AM - 07:00 PM	Abstract	095 - Immortalized Human Neuronal Progenitor Cells (ReNcell CX) Represent an Ideal Model to Investigate the Inhibition of Adult Neurogenesis in the SVZ Mediated by TGF-β Sabrina Kuespert, PhD
08:30 AM - 07:00 PM	Abstract	096 - Immunmodulatory Effects of Intrathecal Administration of Human Immunoglobulins in Experimental Autoimmune Neuritis Model in Lewis Rats Kalliopi Pitarokoili, MD
08:30 AM - 07:00 PM	Abstract	097 - Effects of Deflazacort on Growth and Development in Juvenile Rats Stephen Wanaski, PhD
08:30 AM - 07:00 PM	Abstract	098 - Changes in Twitch Morphometry of Gastrocnemius Muscle in the SOD1 G93A Mouse Model
08:30 AM - 07:00 PM	Abstract	099 - Hyperglycemia Enhanced Human Schwann Cells Sensitivity to Hypoxia
08:30 AM - 07:00 PM	Abstract	100 - Diagnostic Neurosonography in Mouse Models of Demyelinating Charcot-Marie-Tooth Diseae Type 1A
08:30 AM - 07:00 PM	Abstract	101 - Phosphodiesterase-3 Inhibitor Cilostazol Ameliorates Motor Impairment of Experimental Autoimmune Neuritis in Lewis Rats via Deviation of Cytokine mRNA Expression Wataru Hagiwara
08:30 AM - 07:00 PM	Abstract	102 - The ALS Stratification Prize-Using the Power of Big Data and Crowdsourcing for Catalyzing Breakthroughs in Amyotrophic Lateral Sclerosis (ALS) Neta Zach, PhD
08:30 AM - 07:00 PM	Abstract	103 - Sympathetic Adrenergic and Cholinergic Innervation of Sweat Glands across a Spectrum of Disease Ningshan Wang, MD, PhD
08:30 AM - 07:00 PM	Abstract	104 - Heterogeneity and Continuum of Clinical Features in Autoimmune Autonomic Ganglionopathy: A Nationwide Survey in Japan Shunya Nakane, MD
08:30 AM - 07:00 PM	Abstract	105 - Autonomic Dysfunction in Familial Amyloid Polyneuropathy Associated with Transthyretin Alanine 60 Variant
08:30 AM - 07:00 PM	Abstract	106 - Familial Amyloidotic Polyneuropathy in Crete, Greece Minas Tzagournissakis, MD
08:30 AM - 07:00 PM	Abstract	107 - QSART Abnormalities in Cold-Induced Sweating Syndrome Type 1 Jannatul Ferdous, MD
08:30 AM - 07:00 PM	Abstract	108 - Autoimmunity & Autonomic Impairment: Preliminary Characterization of a Clinical Syndrome with Sjögren’s Features Associated with Novel Organ Specific Antibodies Mark Gudesblatt, MD
08:30 AM - 07:00 PM	Abstract	109 - Now its Fabry's- Now its Not-A diagnostic challenge Thomas C. Chelimsky, MD
08:30 AM - 07:00 PM	Abstract	110 - Empiric Treatment of Suspected Autoimmune Autonomic Neuropathies Glen A. Cook, Jr., MD, FAAN
08:30 AM - 07:00 PM	Abstract	111 - B12 Deficiency Is a Cause of Reversible Autonomic Failure: A Case Report Pariwat Thaisetthawatkul, MD, FAAN
08:30 AM - 07:00 PM	Abstract	112 - Obstructive Sleep Apneas Are More Common Than Central Sleep Apneas in Patients with Mild Familial Dysautonomia Max J. Hilz, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	113 - Cognitive and Behavioral Side Effects in Patients Treated with Droxidopa for Neurogenic Orthostatic Hypotension Katherine McDonell, MD
08:30 AM - 07:00 PM	Abstract	114 - Orthostatic Cerebral Blood Flow Velocity Drop Depends on the Duration of Orthostatic Hypotension in Patients with Sympathetic Failure Peter Novak, MD
08:30 AM - 07:00 PM	Abstract	115 - Electrochemical Skin Conductance in Autonomic Synucleinopathies Horacio C. Kaufmann, MD, FAAN
08:30 AM - 07:00 PM	Abstract	116 - Joint Hypermobility Syndrome in a Postural Orthostatic Tachycardia Syndrome (POTS) Cohort Brent P. Goodman, MD
08:30 AM - 07:00 PM	Abstract	117 - Autonomic Dysfunction in Autism Spectrum Disorders (ASD) Brent P. Goodman, MD
08:30 AM - 07:00 PM	Abstract	118 - Autonomic Symptoms Endorsed by Adults with Autism Spectrum Disorders Bryan K. Woodruff, MD
08:30 AM - 07:00 PM	Abstract	119 - Fingolimod Seems to Dampen Cardiac Autonomic Modulation at the Cardiac but Not the Central Level Max J. Hilz, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	120 - Shapiro Syndrome with Agenesis of Corpus Callosum and Hyperhidrosis: A Case Report Christopher S. Nance, MD
08:30 AM - 07:00 PM	Abstract	121 - The Utility of Valsalva Maneuver in the Diagnosis of Orthostatic Disorders
08:30 AM - 07:00 PM	Abstract	122 - Military Personnel with Traumatic Stress Demonstrate Improved Autonomic Cardiovascular Regulation After Use of a Closed Loop Neurotechnology Catherine Tegeler
08:30 AM - 07:00 PM	Abstract	123 - Orthostatic Hypotension and Near-Total Cervical Artery Atherosclerotic Occlusion - A Case Report Claudia Z. Chou, MD
08:30 AM - 07:00 PM	Abstract	124 - Delayed Orthostatic Hypotension Variants Pearl K. Jones, MD
08:30 AM - 07:00 PM	Abstract	125 - Number-Needed-to-Treat Analysis of Droxidopa in Patients with Symptomatic Neurogenic Orthostatic Hypotension
08:30 AM - 07:00 PM	Abstract	126 - Integrated Cardiovascular Safety Profile of Droxidopa Gerry Rowse
08:30 AM - 07:00 PM	Abstract	127 - Analysis of the Incidence of Supine Hypertension with Droxidopa Lawrence Hewitt, PhD
08:30 AM - 07:00 PM	Abstract	128 - Durability of Effect With Long‐Term Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension Stuart H. Isaacson, MD, FAAN
08:30 AM - 07:00 PM	Abstract	129 - Effect of Age on the Efficacy and Safety of Droxidopa for Symptomatic Neurogenic Orthostatic Hypotension
08:30 AM - 07:00 PM	Abstract	130 - Responder Analyses of Droxidopa in Patients with Symptomatic Neurogenic Orthostatic Hypotension Gerry Rowse
08:30 AM - 07:00 PM	Abstract	131 - Rationale and Design of the Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy (RESTORE) Study Randall Owen
08:30 AM - 07:00 PM	Abstract	132 - Development of a Neurogenic Orthostatic Hypotension Activities of Daily Living (nOH -ADL) Scale Clement Francois
08:30 AM - 07:00 PM	Abstract	133 - Analytical Performance of a Genome-Phenome Analyzer for Use in a Clinical Laboratory Joseph J. Higgins, MD, FAAN
08:30 AM - 07:00 PM	Abstract	134 - Diagnostic Whole Exome Sequencing to Study a Cohort of Greek Patients with Heterogeneous Neurological and Other Disorders Zaganas Ioannis, DO
08:30 AM - 07:00 PM	Abstract	135 - Extended Clinical Spectrum of Anti-NMDA Receptor Encephalitis in Children Ajay Goenka, MD
08:30 AM - 07:00 PM	Abstract	136 - Anti-N-methyl-D-Aspartate Receptor Encephalitis in 7-Month Old Infant Following Influenza Vaccination Teodora Cartisano, MD
08:30 AM - 07:00 PM	Abstract	137 - A Pediatric Patient with ANNA-1 Associated Opsoclonus Myoclonus and Epilepsia Partialis Continua Michael Sweeney, MD
08:30 AM - 07:00 PM	Abstract	138 - Neuromyelitis Optica Spectrum Disorders (NMOSD) and AQP4-IgG in an Australian Pediatric Demyelination Cohort Ariel Dahan
08:30 AM - 07:00 PM	Abstract	139 - Acute Disseminated Encephalomyelitis. A Fourteen Years Review
08:30 AM - 07:00 PM	Abstract	140 - AQP4 Antibody-Seropositive Neuromyelitis Optica in a Pediatric Patient Presenting with Severe Generalized Pruritus and Behavior Changes Elizabeth A. Ng, MD, FAAP, FAANEM, FACNS, FAES
08:30 AM - 07:00 PM	Abstract	141 - Motor Deficits Mask Functional Integrity in Pediatric Anoxic Brain Injury with Nonfatal Drowning Mariam Ishaque
08:30 AM - 07:00 PM	Abstract	143 - Novel Homozygous Nonsense Mutation in the ROBO3 gene causing Torticollis and Horizontal Gaze Palsy with Progressive Scoliosis: A Tale of Two Brothers William S. Baek, MD, FAAN
08:30 AM - 07:00 PM	Abstract	144 - Dystonia in POLR3-related leukodystrophy Ghalia Y. Alyazidi, MD
08:30 AM - 07:00 PM	Abstract	145 - A 15 year-old girl with progressive epileptic encephalopathy, myoclonus, and compound heterozygous FARS2 mutations Melissa A. Walker, MD, PhD
08:30 AM - 07:00 PM	Abstract	146 - Exome Sequencing Identifies Dual Mutations in Calcium Signaling Genes GNAO1 and ATP2B3 in a Patient with Early Infantile Epileptic Encephalopathy (EIEE) Keisuke Ueda, MD
08:30 AM - 07:00 PM	Abstract	147 - A Case Series Expanding the Phenotypic Variations in Spinal Muscular Atrophy Type I Michael A. Lopez, MD, PhD
08:30 AM - 07:00 PM	Abstract	148 - The Relationship Between BDNF and the Wnt Signaling Pathway in the Growth of Human Neural Stem Cell Liyan Li
08:30 AM - 07:00 PM	Abstract	149 - Intrathecal Interferon Signaling Genes Expression in Leukodystrophies with Calcifying Microangiopathy on Neuropathology Guy T. Helman
08:30 AM - 07:00 PM	Abstract	150 - Dopa-responsive akinesia: Homozygous GCH1 mutation Christina Lineback, MD
08:30 AM - 07:00 PM	Abstract	151 - Epilepsy and Cognition in Infants with Tuberous Sclerosis Complex:Can Early Identification of Epilepsy Severity Yield Better Cognitive Outcomes? Rujuta B. Wilson, MD
08:30 AM - 07:00 PM	Abstract	152 - Brain Lesions in Asymptomatic Patients with X-Linked Adrenoleukodystrophy
08:30 AM - 07:00 PM	Abstract	153 - Evaluation of the Prevalence of Pharmacogenetic Polymorphisms in Pediatric Neurology Patients with Whole Exome Sequencing Shannon M. DiCarlo, MD, FAAN
08:30 AM - 07:00 PM	Abstract	154 - Analysis of 141 Epilepsy Related Genes Using Next Generation Sequencing in 390 Patients Zhenyuan Wang, PhD
08:30 AM - 07:00 PM	Abstract	155 - Diagnostic Yield and Treatment Impact of Targeted Whole Exome Sequencing in Early Onset Epilepsy Sarah E. Buerki, MD
08:30 AM - 07:00 PM	Abstract	156 - Electroclinical Phenotypes and Outcomes in TBC1D24-Related Epilepsy Brian L. Appavu, MD
08:30 AM - 07:00 PM	Abstract	157 - Genetic Association with Ictal Cardiorespiratory Phenomena: SCN8A Case Series Ammar Hussain, MD
08:30 AM - 07:00 PM	Abstract	158 - Progressive Myoclonus Epilepsy Caused by SACS Mutations Fabio Nascimento, MD
08:30 AM - 07:00 PM	Abstract	159 - Natural History of Succinic Semialdehyde Dehydrogenase Deficiency through Adulthood Samuel Lapalme-Remis, MD
08:30 AM - 07:00 PM	Abstract	160 - Outcomes of Genetic Generalized Epilepsy at a Comprehensive Epilepsy Center Sarita W. Maturu, MD
08:30 AM - 07:00 PM	Abstract	161 - Epilepsy Treatment Patterns among Patients with Tuberous Sclerosis Complex Steven P. Sparagana, MD, FAAN
08:30 AM - 07:00 PM	Abstract	162 - A Rare Case of Progressively Expanding Total Hemimegalencephaly Jayson D. Rodriguez, MD
08:30 AM - 07:00 PM	Abstract	163 - The Frequency of Damaging Genetic Variants in a Cohort of Over 1500 Patients with Early Onset Familial Alzheimer’s Disease
08:30 AM - 07:00 PM	Abstract	164 - A rare coding variant in TREM2 increases risk for Alzheimer’s disease in Han Chinese
08:30 AM - 07:00 PM	Abstract	165 - The Questionable Role of GWA in Identification of Genetic Risk Factors for Alzheimer’s Disease
08:30 AM - 07:00 PM	Abstract	166 - Role of INPP5D, PTK2B, ZCWPW1 and TREM 2 in Predicting Risk of Progression in Cognitively Impaired Subjects to Alzheimer's Disease Connor Hawkins
08:30 AM - 07:00 PM	Abstract	167 - Poor Cognitive Outcomes Are Associated with UNC5C Intronic Polymorphisms Independent of Pathologies Hyun-Sik Yang, MD
08:30 AM - 07:00 PM	Abstract	168 - Epigenetic Evidence That C9orf72 Promoter Hypermethylation Is Protective: A Blinded Replication Corey McMillan, PhD
08:30 AM - 07:00 PM	Abstract	169 - Association of Genetic Variation and Neuropsychiatric Symptoms in 4-Repeat Tauopathies Kylie Ternes, MD
08:30 AM - 07:00 PM	Abstract	170 - Literature Review of Genetic Disorders with tau Pathology Pawel Tacik, MD
08:30 AM - 07:00 PM	Abstract	171 - A Novel POLR1C Mutation Causing Autosomal Recessive Adult-Onset Leukodystrophy Michael D. Geschwind, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	173 - Plasma Aβ Levels Are Correlated with Cognitive and Motor Functions in Iwaki Health Promotion Project Takumi Nakamura, MD
08:30 AM - 07:00 PM	Abstract	174 - The Role of Age on Beta-Amyloid1-42 Plasma Levels in Healthy Subjects Chiara Zecca, MD
08:30 AM - 07:00 PM	Abstract	176 - Sleep EEG Changes in Preclinical Alzheimer Disease: A Pilot Study Sonja G. Schuetz, MD
08:30 AM - 07:00 PM	Abstract	177 - Optical Coherence Tomography as Potential Biomarker in Parkinson’s Disease and Alzheimer’s Disease
08:30 AM - 07:00 PM	Abstract	178 - Myelin Basic Protein Is Associated with White Matter Integrity in 4-Repeat Tauopathies
08:30 AM - 07:00 PM	Abstract	180 - Higher Levels of hs-CRP Related to Corpus Callosum Volume in the Elderly
08:30 AM - 07:00 PM	Abstract	181 - Biomarker Confirmed Alzheimer’s Disease Presenting as Amnestic, Aphasic, and Visual Variants: Hippocampal Volume Comparison Alissa Butts
08:30 AM - 07:00 PM	Abstract	182 - Development of a Diagnostic Decision Tree for Rapidly Progressive Dementia Jeffrey M. Gelfand, MD, MS, FAAN
08:30 AM - 07:00 PM	Abstract	183 - Rapidly Progressive Alzheimer’s Disease in Two Distinct Autopsy Cohorts Jagan Pillai, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	184 - Differentiating individuals with cognitive complaints due to corticobasal degeneration and Alzheimer disease by clinical features Gregory S. Day, MD, MSc, FAAN
08:30 AM - 07:00 PM	Abstract	185 - A Case of Familial Prion Disease Caused by a Six-Octapeptide Repeat Insertion Mutation Christopher T. Doughty, MD
08:30 AM - 07:00 PM	Abstract	186 - Clinical Utility of Amyloid Imaging in Differential Diagnosis of Atypical/Unclear Dementias and Its Impact on Caregivers Robert Laforce, Jr., MD, PhD
08:30 AM - 07:00 PM	Abstract	187 - Definite Fatal Familial Insomnia (FFI) Disease with Voltage-Gated Potassium Channel (VGKC)-Complex Autoimmunity: A Rare Case of Molecular Mimicry or Incidental Finding? Sirisha Sanamandra, MBBS
08:30 AM - 07:00 PM	Abstract	188 - Amyloid Beta-Related Angiitis (ABRA) with Rapidly Progressive Dementia and Myoclonia, Thus Mimicking CJD Wolfgang Heide, MD, FEAN
08:30 AM - 07:00 PM	Abstract	189 - Functional and Structural Brain Alterations in Patients with Posterior Cortical Atrophy
08:30 AM - 07:00 PM	Abstract	190 - Hickam’s dictum: Creutzfeldt Jakob disease in a patient with concurrent stage IV esophageal carcinoma Michael A. Lane, MD
08:30 AM - 07:00 PM	Abstract	191 - Dissociations in Socioemotional Test Performance Predict Neurodegeneration in Intrinsic Connectivity Networks Natanya S. Russek
08:30 AM - 07:00 PM	Abstract	192 - Cognitive Symptoms Questionnaire. A Novel Reliable and Quick Survey in Spanish for the Assessment of Cognitive Impairment Marcos C. Fernandez Suarez, MD
08:30 AM - 07:00 PM	Abstract	193 - Dissociable Substrates Underlie the Production of Abstract and Concrete Nouns
08:30 AM - 07:00 PM	Abstract	194 - Evidence of Social Norm Deficits in Progressive Supranuclear Palsy
08:30 AM - 07:00 PM	Abstract	195 - Neuropsychiatric Symptoms in Early Autosomal Dominant and Late Onset Alzheimer’s Disease Nicholas T. Olney, MD
08:30 AM - 07:00 PM	Abstract	196 - Indifference to Sweaty Feet: Reward Deficits in Behavioral Variant Frontotemporal Dementia Include Insensitivity to Negative Stimuli
08:30 AM - 07:00 PM	Abstract	197 - The TabCAT Brain Health Assessment: A Highly Efficient and Sensitive Approach to Detecting Very Mild Cognitive Impairment Tacie Moskowitz
08:30 AM - 07:00 PM	Abstract	198 - It’s Not Just How Much: The Effects of Night-to-Night Variability in Sleep Patterns on Working Memory Christine M. Walsh, PhD
08:30 AM - 07:00 PM	Abstract	199 - Now you see it; now you don’t: one of the best established age-related changes in neural activity vanishes after controlling for visual acuity Fabio H. Porto, MD
08:30 AM - 07:00 PM	Abstract	200 - Neuropsychological Profile in Carriers of E46K Mutation of the alpha-Synuclein Gene
08:30 AM - 07:00 PM	Abstract	201 - Zinc, Copper and Manganese Porphyrins Restore Mitochondrial Function and Improve Cognition without Reducing Aβ Levels in Alzheimer's Mice and Cells Natasa Dragicevic, MD, PhD
08:30 AM - 07:00 PM	Abstract	202 - When Pigs Fly: Dynamic Susceptibility Contrast MRI for Cerebral White Matter Injury in a Hypobaric Swine Model Philippine Dana Peralta, MD
08:30 AM - 07:00 PM	Abstract	203 - Role of an Endogenous Retrovirus in ALS Pathophysiology and Effect of Anti-Retrovirals In Vitro Avindra Nath, MD, MBBS, FAAN
08:30 AM - 07:00 PM	Abstract	204 - Combination Therapy with Doxycycline, Chlorpromazine or Quinacrine Inhibits Prion Protein Replication in a N2A Model Adam Witt, MD
08:30 AM - 07:00 PM	Abstract	205 - Neuroprotective Effects of Ezetimibe versus Simvastatin in Alzheimer’s Induced Dementia: Perspectives from Female Rats.
08:30 AM - 07:00 PM	Abstract	207 - Cognition, Plaques and PACAP in Aged APP Transgenic Mice-A Quantitative Evaluation Peng Cheng Han, PhD
08:30 AM - 07:00 PM	Abstract	208 - Neuroprotective Properties of Apo6856, a Novel Hydroxypyridinone Iron Chelator, in Alzheimer’s Disease Marina Premyslova, PhD
08:30 AM - 07:00 PM	Abstract	209 - Hypoxia Inducible Factor 1α Mediates Neuroprotective Role in Rat Model of Chronic Cerebral Hypoperfusion Ying Yang
08:30 AM - 07:00 PM	Abstract	210 - Intracranial and Extracranial Stenosis interact with White Matter Disease in the Pathogenesis of Post Stroke Dementia
08:30 AM - 07:00 PM	Abstract	212 - Durability of Antiplatelet Effect of a Novel Extended-Release Formulation of Acetylsalicylic Acid, Durlaza, in Patients with Diabetes
08:30 AM - 07:00 PM	Abstract	213 - Pharmacogenetics of CYP2C19 Genetic Polymorphism on Clopidogrel Response in Patients with Ischemic Stroke from Saudi Arabia Adel Alhazzani, MD, FRCPC, FAAN
08:30 AM - 07:00 PM	Abstract	214 - Angiotensin II Increases Glymphatic Flow Through a Norepinephrine-Dependent Mechanism Adam Russak
08:30 AM - 07:00 PM	Abstract	215 - Factors Affecting Blood Pressure Control Post-Stroke Julie McDaniel, MD
08:30 AM - 07:00 PM	Abstract	216 - Inconsistent Systolic Blood Pressure Management and Poor Documentation During Transfer to a Comprehensive Stroke Center Is Associated with Worsening Patient Outcomes Thomas V. Kodankandath, MD, FAAN
08:30 AM - 07:00 PM	Abstract	217 - Low HDL Cholesterol Levels (HDL-C) Associated with a Higher Risk of Infections in Patients Hospitalized for Acute Ischemic Stroke (iStroke) Santiago M. Pagano Ajolfi, Sr., MD
08:30 AM - 07:00 PM	Abstract	218 - Burden and Outcomes of Acute Ischemic Stroke in Patients with Cirrhosis Abhishek Lunagariya, MD
08:30 AM - 07:00 PM	Abstract	219 - Risk Association between TNF-308G>A and IL-6 -174 G/C Polymorphisms and Recurrent Transient Ischemic Attacks Hassan H. Salama, MD, PhD
08:30 AM - 07:00 PM	Abstract	221 - A Modified Method for Creating Elastase Induced Aneurysms and Characterization of Intra-Aneurysmal Flow Cyrus Safinia
08:30 AM - 07:00 PM	Abstract	222 - Proinflammatory Lipids Are Elevated, Serum Amyloid A Is Increased and Paraoxonase Activity Is Decreased Following Administration of Oxidized Phospholipids in a Mouse Model of Inflammation Luis Salazar
08:30 AM - 07:00 PM	Abstract	223 - Oxidized Phospholipids in the Brain of LDL Receptor Deficient Mice on a High Fat High Cholesterol Diet Are Significantly Reduced by the Anti Inflammatory Peptide F Samra Vazirian, MD
08:30 AM - 07:00 PM	Abstract	224 - Effect of Rehabilitation on Oligodendrocyte Progenitor Cells in a Mouse Model of White Matter Stroke Candace B. Borders, MD
08:30 AM - 07:00 PM	Abstract	225 - Comparisons Between Different Rodent Stroke Scales: Optimizing Resource Allocation in Rat Models of Focal Middle Cerebral Artery Occlusion Salam Bachour
08:30 AM - 07:00 PM	Abstract	226 - Neurovascular Uncoupling in Acute Ischemic Stroke Correlates with Clinical Fluctuations in Acute Ischemic Stroke Jonathan J. Ong, MD
08:30 AM - 07:00 PM	Abstract	227 - Hepatic S1P Deficiency Reduces Atheroma Formation in LDLR-/- Mice Weijun Jin, MD
08:30 AM - 07:00 PM	Abstract	228 - P38 Mitogen Activated Protein Kinase alpha (MAPKα) Inhibition to Promote Neurologic Recovery in Rat Stroke Transient Middle Cerebral Artery Occlusion (t-MCAO) Model John Alam
08:30 AM - 07:00 PM	Abstract	229 - Continuous Intra-Arterial Catheter Access of Ischemic Cerebral Tissue Pradeep N. Selvan, MD
08:30 AM - 07:00 PM	Abstract	230 - FTY720 Preserves Blood-Brain Barrier Integrity Following Subarachnoid Hemorrhage in Rats Abdullah Muhammad
08:30 AM - 07:00 PM	Abstract	231 - Oligodendrocyte as a New Target of Cilostazol in Protection of the White Matter from Demyelination Caused by Chronic Cerebral Ischemia Ryo Ohtomo, MD
08:30 AM - 07:00 PM	Abstract	232 - Expanding the Spectrum of Subacute Diencephalic Angioencephalopathy Elliot T. Dawson, MD, FAAN
08:30 AM - 07:00 PM	Abstract	233 - Fasting Serum Apolipoprotein B48 Is a Risk Factor for Large Artery Atherosclerotic Stroke
08:30 AM - 07:00 PM	Abstract	234 - Significance of BNP for Neurological Severity in Acute Ischemic Stroke Takahiro Kuwashiro
08:30 AM - 07:00 PM	Abstract	235 - Neutrophils/Lymphocytes Ratio and Platelets/Lymphocytes Ratio and Its Relationship with Severity and Functional Prognosis in Patients with Acute Ischemic Stroke
08:30 AM - 07:00 PM	Abstract	236 - Association between Serum Alkaline Phosphatase Level and Cerebral Small Vessel Disease Seung-Hun Oh, MD
08:30 AM - 07:00 PM	Abstract	237 - Modified SPAN-100 index in patients with Intracerebral hemorrhage: Correlation and outcomes Cyrus G. Escabillas, MD
08:30 AM - 07:00 PM	Abstract	238 - Serum-Albumin level and Albumin/Globulin ratio as predictors of short- term outcome of first ever ischemic stroke Gharib F. Ibrahim, MD, FAAN
08:30 AM - 07:00 PM	Abstract	240 - Von Willebrand Factor Plasmatic Levels and Multimeric Analysis in Patients with Atrial Fibrilation and Stroke in Mexican Population. It Is a Stroke Biomarker? Guillermo Punzo Bravo, MD, PhD
08:30 AM - 07:00 PM	Abstract	242 - Pathogenicity of Rasmussen Encephalitis CD8+ Lymphocytes Elucidated by Large-Scale Sequencing of the T-Cell Receptor Repertoire
08:30 AM - 07:00 PM	Abstract	243 - Using the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-350 to Reduce Cortical Circuit Hyperexcitability and Interneuron Cell Loss in the Controlled Cortical Impact (CCI) Model of Traumatic Brain Injury (TBI) David Cantu, PhD
08:30 AM - 07:00 PM	Abstract	244 - Investigating the Involvement of GPR55 Signaling in the Antiepileptic Effects of Cannabidiol Michael Bazelot, PhD
08:30 AM - 07:00 PM	Abstract	245 - Localization of Inflammation in the Epileptic Rat Brain by Bi-Functional Fluorescent and Magnetic Nanoparticles Sara Eyal, PhD
08:30 AM - 07:00 PM	Abstract	246 - Evidence for a Differential Interaction of Brivaracetam and Levetiracetam with the SV2A Protein
08:30 AM - 07:00 PM	Abstract	247 - Protective Effects of Choline Alfoscerate on Seizure-Induced Neuron Death and Cognitive Impairment Hongki Song
08:30 AM - 07:00 PM	Abstract	248 - A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures with a Seizure Detection and Warning System in Epilepsy - Brain Sentinel® Device Jose E. Cavazos, MD, PhD
08:30 AM - 07:00 PM	Abstract	249 - Circadian Patterns of Epileptiform Discharges Differ by Seizure Onset Location During Chronic, Long-Term Intracranial Monitoring David C. Spencer, MD, FAAN
08:30 AM - 07:00 PM	Abstract	250 - Long-Term Outcome of Adults with Medically Intractable Neocortical Seizures Treated with Brain Responsive Neurostimulation Barbara C. Jobst, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	251 - The Long-Term Outcome of Children with Refractory Epilepsy after a Vagal Nerve Stimulator Implantation: CHU Sainte-Justine Experience Matsanga L. Kaseka, MD
08:30 AM - 07:00 PM	Abstract	252 - Microenvironmental Regulation of Glioblastoma
08:30 AM - 07:00 PM	Abstract	253 - Assessing the Components of a Novel VEGF Signalling Cascade as Potential Prognostic Markers in Glioblastoma
08:30 AM - 07:00 PM	Abstract	254 - Genomic Profile, Radiological and Clinical Features of IDH Wild-Type WHO Grades II and III Glioma Xuling Lin, MD
08:30 AM - 07:00 PM	Abstract	255 - Impact of IDH-1 Mutation Status on Outcome in Clinical Trials for Recurrent Glioblastoma Jacob Mandel, MD
08:30 AM - 07:00 PM	Abstract	256 - Molecular and Clinical Characterization of Gliosarcomas Synphen Wu, MD, PhD
08:30 AM - 07:00 PM	Abstract	257 - Clinical and Molecular Characterization of Glioneuronal Tumors Julie J. Miller, MD, PhD
08:30 AM - 07:00 PM	Abstract	258 - Using ACT1, a Connexin 43 Blocker, Against Glioblastoma Stem Cells Pratik Kanabur
08:30 AM - 07:00 PM	Abstract	259 - Ionizing Radiation Induces Autophagy in Human Microglial Cells Nizar Souayah, MD, FAAN
08:30 AM - 07:00 PM	Abstract	260 - Paraneoplastic Cerebellar Degeneration (PCD) Syndrome in Diffuse Large B-cell Lymphoma (DLBCL): expanding the spectrum of malignancies associated with cerebellar degeneration Vasu Saini, MD
08:30 AM - 07:00 PM	Abstract	261 - Ionizing Radiation Induces Cellular Senescence in Human Microglial cells
08:30 AM - 07:00 PM	Abstract	262 - Chronic Gastrointestinal Dysmotility in Adult m.3243A>G-Related Mitochondrial Disease: An Under-Recognised and Under-Treated Clinical Entity Yi Shiau Ng
08:30 AM - 07:00 PM	Abstract	263 - Leukodystrophy and Neurogenic EMG Changes Associated with Variants in POLR3A and PMP22 Anand Venkatraman, MBBS
08:30 AM - 07:00 PM	Abstract	264 - Susceptibility to MELAS Exacerbations in a POLG1 Mutation Carrier Divya S. Nadkarni, MD
08:30 AM - 07:00 PM	Abstract	265 - Fhl1 W122S Mutant Female Mice Develop Late-Onset Cardiomyopathy
08:30 AM - 07:00 PM	Abstract	266 - A Novel Mutation of SPAST Gene in Family Members Presenting with Spastic Paraparesis Mohammed Elkider, MBBS
08:30 AM - 07:00 PM	Abstract	267 - Periventricular Heterotopia and Ehlers-Danlos Syndrome: An Underdiagnosed Association? Manuel Seijo-Martinez, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	268 - CSF Markers of Inflammation and Neurodegeneration in Two Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS) Families with Diverging Genotype and Phenotype Virginija D. Karrenbauer, MD, PhD
08:30 AM - 07:00 PM	Abstract	269 - Retinal Vasculopathy and Cerebral Leukodystrophy (RVCL) in a Spanish Family Leticia Alvarez
08:30 AM - 07:00 PM	Abstract	270 - Identification of the Protective Role of DJ-1 in Hypoglycemic Astrocyte Injury Using Proteomics
08:30 AM - 07:00 PM	Abstract	271 - A Case of Tapia’s Syndrome: Iatrogenic Hypoglossal and Recurrent Laryngeal Nerve Palsy Jared Noroozi, MD
08:30 AM - 07:00 PM	Abstract	272 - The Retinoid X Receptor (RXR) Selective Agonist IRX4204 Promotes Differentiation of Human Treg Cells and Inhibits Differentiation of Human TH17 Cells Daniel Mielcarz
08:30 AM - 07:00 PM	Abstract	273 - MerTK as a Functional Regulator of Anti-Inflammatory Myelin Phagocytosis by Human Myeloid Cells
08:30 AM - 07:00 PM	Abstract	274 - The HLA-haplotype (DRB11501/DQB10602) is not primarily responsible for its apparent association with MS Douglas S. Goodin, MD
08:30 AM - 07:00 PM	Abstract	275 - Variants within the Leptin Receptor Gene (LEPR) on Chromosome 1p31 Are Associated with MS Susceptibility in a Model Adjusted for Known Disease Risk Factors
08:30 AM - 07:00 PM	Abstract	276 - Anti-KIR4.1 antibodies do not differentiate multiple sclerosis patients from controls
08:30 AM - 07:00 PM	Abstract	277 - Dynamics of Th17 Cells during and after Cessation of Natalizumab Therapy Brigitte Wildemann, MD
08:30 AM - 07:00 PM	Abstract	278 - HLA-DRB1*1501 Is Associated with Retinal Deterioration in Multiple Sclerosis Dorlan J. Kimbrough, MD
08:30 AM - 07:00 PM	Abstract	279 - iPhemap: An Atlas of Phenotype to Genotype Relationships of Human Induced Pluripotent Stem Cell Models of Neurological Diseases Jaime Imitola, MD, FAAN
08:30 AM - 07:00 PM	Abstract	280 - Finding Novel Candidate Genes for Human Cortical Neurons and Corpus Callosum in Obscure Regions of the Genome Jaime Imitola, MD, FAAN
08:30 AM - 07:00 PM	Abstract	281 - Reversible Effects of Daclizumab HYP on Lymphocyte Counts in RRMS Patients: Data from the SELECT Trilogy Studies Sami Fam
08:30 AM - 07:00 PM	Abstract	282 - TERI-DYNAMIC: Exploring the Impact of Teriflunomide on Immune Cell Population Size, Receptor Repertoire, and Function in Patients With RRMS
08:30 AM - 07:00 PM	Abstract	283 - Tecfidera Modulates Transcriptional Expression of Genes Involved in Regulation of the Immune Response and Antigen Processing
08:30 AM - 07:00 PM	Abstract	284 - A Proteomics Approach for the Identification of Cerebrospinal Fluid Proteins Associated with Conversion to Multiple Sclerosis Murat Kurtuncu, MD
08:30 AM - 07:00 PM	Abstract	285 - Exosomal miRNA as Biomarkers for Disease Activity in RR MS Krzysztof W. Selmaj
08:30 AM - 07:00 PM	Abstract	286 - IFN-b-1a Therapy Induces the Expansion of TGF-β1-Producing B-Cells and FOXP3+ T-Regulatory Cells in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Silva Markovic-Plese, MD, FAAN
08:30 AM - 07:00 PM	Abstract	287 - The Melanocortin Receptor ACTH1-39 May Protect Oligodendroglia by Inhibiting Protein Kinase C Robert P. Lisak, MD, FAAN
08:30 AM - 07:00 PM	Abstract	288 - Haematologic Modifications as Markers of Response to Treatment in Multiple Sclerosis Patients Treated with Natalizumab Nuala McNicholas, MBBS
08:30 AM - 07:00 PM	Abstract	289 - Cell Type-Specific Gene Expression Changes in the Blood of Multiple Sclerosis Patients in the Early Phase of Interferon-beta Treatment Michael Hecker, PhD
08:30 AM - 07:00 PM	Abstract	290 - Genomic Analysis of Co-Regulated Genes Associated with Neural Stem Cells Identifies Pathways for Self-Renewal Capacity and Oncogenic Potential in Neurospheres Maria del Pilar Guillermo Prieto Eibl, MD
08:30 AM - 07:00 PM	Abstract	291 - Additional Mode of Action? Fingolimod Inhibits the IL-33 Induced IFN‑γ Formation in CD8+ and Affects the Formation of Bioactive Sphingolipids in Patients with Multiple Sclerosis Florian Ottenlinger
08:30 AM - 07:00 PM	Abstract	292 - Longitudinal Analysis of Natalizumab Treated Multiple Sclerosis (MS) Patients Using PK11195-PET Demonstrates Reduced CNS Inflammation Ulrike Kaunzner, MD
08:30 AM - 07:00 PM	Abstract	293 - Clinical and Biochemical Pictures of Anti-Neutral Glycolipids Antibody-Positive Central and Peripheral Nervous System-Involving Disorders Tatsuro M. Mutoh, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	294 - Lymphocyte Dynamics During and After Fingolimod Therapy: Long-Term Data from the INFORMS Trial Fred D. Lublin, MD, FAAN
08:30 AM - 07:00 PM	Abstract	295 - Neuronal Uptake of Paraneoplastic IgG Autoantibodies Reactive with Intracellular Antigens Requires the Fc Portion of the IgG Molecule and Can Be Competitively Inhibited by Normal IgG John E. Greenlee, MD, FAAN
08:30 AM - 07:00 PM	Abstract	296 - Preferential Entrapment of Naive T Cells Associates with a Less Diverse T Cell Receptor Repertoire in MS Patients Treated with Fingolimod Clemens Warnke
08:30 AM - 07:00 PM	Abstract	297 - Metabolomic Networks Associated with Changes in Cytokine Expression Differ in Multiple Sclerosis Patients and Healthy Controls Following Vitamin D Supplementation Kathryn Fitzgerald, PhD
08:30 AM - 07:00 PM	Abstract	298 - LINGO-1 Negatively Regulates Oligodendrocyte Differentiation by Blocking the β-integrin Signaling Pathway Sha Mi, PhD
08:30 AM - 07:00 PM	Abstract	299 - Transcriptome Profiles from Relapsing-Remitting Multiple Sclerosis Patients Show Aberrant Immunological Phenotypes Compared with Healthy Controls
08:30 AM - 07:00 PM	Abstract	300 - Medusa Head-Type Neuronal Autoantibody Inositol Triphosphate Receptor-1 (ITPR1)-IgG: Frequency, Clinical Phenotype and Cancer Associations Nora B. Alfugham, MD
08:30 AM - 07:00 PM	Abstract	301 - Antibody Against Inward Rectifying Potassium Channel KIR4.1 in Turkish Patients with Neuromyelitis Optica Egemen Idiman, MD
08:30 AM - 07:00 PM	Abstract	302 - Prospective Study of NMO Spectrum Disorder: Disease Pattern Based on Antibody Status Pranav B. Joshi, MD, DNB
08:30 AM - 07:00 PM	Abstract	303 - Expanding the Range of Immuno-pathology in Neuro-Myelitis Optica Spectrum Disorder Jennifer C. Massey, MBBS
08:30 AM - 07:00 PM	Abstract	304 - The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis Helle Hvilsted Nielsen, MD, PhD
08:30 AM - 07:00 PM	Abstract	305 - Increased IL-10-producing B-lymphocytes in the Peripheral Blood of Neuromyelitis Optica Treated Patients
08:30 AM - 07:00 PM	Abstract	306 - Autoimmune AQP4 Channelopathy and Bradycardia: Expanding the NMOSD Spectrum Masoud Majed, MD
08:30 AM - 07:00 PM	Abstract	307 - Prospectively tracking disease course and treatment changes in Neuromyelitis Optica using NMOBase, a global online registry. Ilya Kister, MD, FAAN
08:30 AM - 07:00 PM	Abstract	308 - Combined VEPs and OCT Help Differentiating Multiple Sclerosis from NMOSD Letizia M. Leocani, MD
08:30 AM - 07:00 PM	Abstract	309 - Practical Experience with Animal Models for Translational Research in MS and NMO Melina Jones, PhD
08:30 AM - 07:00 PM	Abstract	310 - Therapeutic Target of Memory B Cells Depletion Helps to Tailor Administration Frequency of Rituximab in Neuromyelitis Optica Spectrum Disorders Patients Christine Lebrun Frenay, MD, FAAN
08:30 AM - 07:00 PM	Abstract	311 - Effects of Siponimod (BAF312) on Inflammation-Driven Synaptopathy in Experimental Multiple Sclerosis Antonietta Gentile
08:30 AM - 07:00 PM	Abstract	312 - Effect of Teriflunomide (Aubagio®) on Cortico-Basal Ganglionic-Thalamo-Cortical Gray Matter Connectivity in Mouse Model of Multiple Sclerosis Claire Modica
08:30 AM - 07:00 PM	Abstract	313 - Nebulization of RNS60 Attenuates the Adoptive Transfer of Experimental Allergic Encephalomyelitis in Mice: Implications for Multiple Sclerosis Susanta Mondal, PhD
08:30 AM - 07:00 PM	Abstract	314 - Pre-Clinical Studies and Evaluation of Treatment Need of Glatiramer Acetate Depot (Long Acting Injection) Nadav Bleich Kimelman
08:30 AM - 07:00 PM	Abstract	315 - Treatment with the Retinoid X Receptor Agonist IRX4204 Ameliorates Active and Passive Experimental Autoimmune Encephalomyelitis in Mice Elizabeth Nowak
08:30 AM - 07:00 PM	Abstract	316 - Ingested (Oral) Rituximab Inhibits EAE Staley A. Brod, MD
08:30 AM - 07:00 PM	Abstract	317 - Long-Term Fingolimod Treatment Does Not Impair Immune Memory in a Preclinical Immunization Model Paul Smith
08:30 AM - 07:00 PM	Abstract	318 - Clinical Application of Frozen Vitamin D3-Tolerogenic Dendritic Cells
08:30 AM - 07:00 PM	Abstract	320 - Treatment of EAE and MS Subjects with Probiotic VSL#3 Stephanie Tankou, MD, PhD
08:30 AM - 07:00 PM	Abstract	321 - B Lymphocytes from MS Patients Induce CNS Pathology in a Murine Brain Slice Model Danielle E. Harlow, PhD
08:30 AM - 07:00 PM	Abstract	322 - Attenuation of Optic Neuritis and Visual Pathway Dysfunction by an Estrogen Receptor Beta Ligand in a Mouse Model of Multiple Sclerosis Seema K. Tiwari-Woodruff, PhD
08:30 AM - 07:00 PM	Abstract	323 - Characterization of a CD52 Knockout Mouse to Investigate the Function of CD52 Michael J. Turner, PhD
08:30 AM - 07:00 PM	Abstract	324 - The Gut Microbiome Affects the Progression of Disease in a Murine Model of Secondary Progressive MS Javier Ochoa-Reparaz, PhD
08:30 AM - 07:00 PM	Abstract	325 - The Sphingosine 1-phosphate (S1P) Receptor Modulator, Siponimod Decreases Oligodendrocyte Cell Death and Axon Demyelination in a Mouse Model of Multiple Sclerosis Seema K. Tiwari-Woodruff, PhD
08:30 AM - 07:00 PM	Abstract	326 - Knock Out of Oligodendroglial FGFR1 Causes Increased TrkB Receptor Expression in C57Bl/6 Mice Ranjithkumar Rajendran
08:30 AM - 07:00 PM	Abstract	327 - CSF-1R Inhibition Results in Protection of Axonal Degeneration and Demyelination in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
08:30 AM - 07:00 PM	Abstract	328 - Neutrophil Derived A Proliferation-Inducing Ligand (APRIL) Potentiates an Inflammatory B-Cell Function in TH17-Induced Neuro-Inflammation
08:30 AM - 07:00 PM	Abstract	329 - Fetuin-A, a CSF Biomarker of Multiple Sclerosis Disease Activity, Is Upregulated at the Blood-CSF Barrier Langan Ruth-Anne
08:30 AM - 07:00 PM	Abstract	330 - The Reduced Susceptibility to Develop CNS-Autoimmunity in the Absence of N-Glycosylation Is Associated to Impaired Differentiation and Function of Induced Regulatory T Cells Felix Bischof
08:30 AM - 07:00 PM	Abstract	331 - Astrocytic Tight Junctions Regulate Inflammatory CNS Lesion Size and Severity Sam H. Horng, MD, PhD
08:30 AM - 07:00 PM	Abstract	332 - The Effect of Heat Shock Protein 70 (HSP70) on the Activity of Notch Signaling Pathway in Myelin-Reactive CD4 T Cells
08:30 AM - 07:00 PM	Abstract	333 - CNS Inflammasome Activation and Modulation in Multiple Sclerosis
08:30 AM - 07:00 PM	Abstract	334 - CSF FROM PROGRESSIVE-MS PATIENTS STIMULATES MICROGLIAL ACTIVATION PATHWAYS IN VIVO AND IN VITRO Kelsey McDermott
08:30 AM - 07:00 PM	Abstract	335 - Thromboxane A2 Levels Are Increased in the CSF of Active Multiple Sclerosis Patients
08:30 AM - 07:00 PM	Abstract	336 - The Relevance of VGKC-Positivity in the Absence of LGI1 and Caspr2 Antibodies
08:30 AM - 07:00 PM	Abstract	337 - IL-33 Expression in MS: Role in Remyelination and Repair Subramaniam Sriram, MD
08:30 AM - 07:00 PM	Abstract	338 - IL-11 Induces Th17-Cell Responses in Relapsing Remitting Multiple Sclerosis (RRMS) Silva Markovic-Plese, MD, FAAN
08:30 AM - 07:00 PM	Abstract	339 - Immune-Regulatory Role of Mucosal-Associated Invariant T Cells (MAIT) in Multiple Sclerosis Jorge D. Correale, MD
08:30 AM - 07:00 PM	Abstract	340 - Oligoclonal IgM Status Identifies Two Different Immune Mechanisms in MS. Correlation with Age Luisa Maria Villar Guimerans, MD
08:30 AM - 07:00 PM	Abstract	341 - Quantification of anti-KIR4.1 Antibodies in Multiple Sclerosis: Difficulties and Acceptance Criteria Antonio Bertolotto, MD, FAAN
08:30 AM - 07:00 PM	Abstract	342 - Assessment of T Cell Lineage-Specific Transcription Factors and Cytokines Expression in Multiple Slcerosis and Neuro-Behçet Disease Patients
08:30 AM - 07:00 PM	Abstract	343 - Lack of CerS2 Suppresses the Development of Experimental Autoimmune Encephalomyelitis by Impairing the Migratory Potential of Neutrophils Christoph Mayer
08:30 AM - 07:00 PM	Abstract	345 - IL-17 and IL-22-Secreting Myelin-Specific CD4+ T Cells Corticosteroid Resistant Are Related to Active Brain Lesions in Multiple Sclerosis Patients Ana Cristina W. Dos Santos
08:30 AM - 07:00 PM	Abstract	346 - Myelin Oligodendrocyte Glycoprotein (MOG) Autoimmunity. A Case Report
08:30 AM - 07:00 PM	Abstract	347 - Estrogen Receptor Alpha- Associated Genomic Regions Are Potential Core of T Cell Subtypes Identity Santina Cutrupi
08:30 AM - 07:00 PM	Abstract	348 - Estrogen Receptor Alpha Regulates Key Genomic Regions of Thelper 17 and T Regulatory Cells in Multiple Sclerosis: A New Potential Biomarker of Disease Activity Marinella Clerico, MD
08:30 AM - 07:00 PM	Abstract	349 - CSF Neurofilament Light Chain Levels as a Biomarker for Pediatric Demyelinating Diseases Soe S. Mar, MD, FAAN
08:30 AM - 07:00 PM	Abstract	350 - Early Identification of Interferon-beta Responders by Assessment of T Cell Lineage-Specific Transcription Factors and Cytokines Expression in Multiple Sclerosis
08:30 AM - 07:00 PM	Abstract	351 - Patients’ Experience of Parkinson’s Disease Following Treatment with Inhaled Levodopa: Results from a Phase 2b Study Peter A. LeWitt, MD
08:30 AM - 07:00 PM	Abstract	352 - Verbal Fluency Trends in Early Stage Parkinsons Disease Patients Following Deep Brain Stimulation: Analysis of Five-Year Extension of a Randomized Pilot Trial
08:30 AM - 07:00 PM	Abstract	353 - MDS Research Criteria for Prodromal Pakrinson's Disease Ronald Postuma, MD
08:30 AM - 07:00 PM	Abstract	354 - Antisense oligonucleotides to LRRK2 ameliorate alpha-synuclein pathology and behavioral deficit induced by pre-formed alpha-synuclein fibrils
08:30 AM - 07:00 PM	Abstract	355 - Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease Jessica A. Karl, PA
08:30 AM - 07:00 PM	Abstract	356 - Phenotypic Differences Between African American and Caucasian Parkinson’s Disease Patients Meagan O. Bailey, MD
08:30 AM - 07:00 PM	Abstract	357 - The Relationship between Nutrient Status and Cognitive Performance in Persons with Parkinson’s Disease Amie L. Hiller, MD
08:30 AM - 07:00 PM	Abstract	358 - Correlates of Parkinsonism in African Americans in Chicago Deborah H. Hall, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	359 - Conjugal Parkinsonism in Autopsy Confirmed Cases Ali H. Rajput, MD, FAAN
08:30 AM - 07:00 PM	Abstract	360 - Risk of Parkinson’s Disease in Patients with Diabetes Mellitus and Other Comorbidities in Taiwan Chia-Ju Lee, MD
08:30 AM - 07:00 PM	Abstract	361 - Levodopa Carbidopa Infusion Gel to Treat Very Advanced idiopathic Parkinson’s disease Jason L. Aldred, MD, FAAN
08:30 AM - 07:00 PM	Abstract	362 - Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel from an Open-Label Study in Japanese, Taiwanese, and Korean Patients with Advanced Parkinson’s Disease Miho Murata
08:30 AM - 07:00 PM	Abstract	363 - α-Synuclein Deposition in the Colon and Premotor Markers of Parkinson’s disease in Neurologically Normal Subjects Joong-Seok Kim
08:30 AM - 07:00 PM	Abstract	364 - The Clinical Utility of Sudoscan as a Biomarker for Parkinson's Disease with Lewy Bodies
08:30 AM - 07:00 PM	Abstract	365 - The Long and the Short of Survival in Parkinsonism Leslie Ferguson, MD
08:30 AM - 07:00 PM	Abstract	366 - Effect of Vibration on Motor Performance: A new Intervention to Improve Bradykinesia in Parkinson’s Disease? Antonella Macerollo
08:30 AM - 07:00 PM	Abstract	367 - 7,8-DHF Ameliorates L-DOPA-Induced Dyskinesia in a Parkinson’s Disease Rat Model
08:30 AM - 07:00 PM	Abstract	368 - Higher LDL-Cholesterol Is Associated with Higher Gyrification during Parkinson's Disease Progression Nicholas Sterling
08:30 AM - 07:00 PM	Abstract	369 - Interaction of Stretch Reflex Loop with Descending B-Oscillations and the Generation of Tremor in Parkinson’s Disease: A Study of Motor Unit Firing Synchrony and Patterns
08:30 AM - 07:00 PM	Abstract	370 - GAITRite Comparison Between Parkinson's Disease Stages Wissam G. Deeb, MD
08:30 AM - 07:00 PM	Abstract	371 - Genetic Etiology of Early-Onset Parkinsonism in Norway Emil K. Gustavsson
08:30 AM - 07:00 PM	Abstract	372 - Effect of Patient Characteristics on Motor Function in Response to 35-50 mg of Inhaled Levodopa (CVT-301) in Patients with Parkinson’s Disease: Results from a Phase 2b Study Peter A. LeWitt, MD
08:30 AM - 07:00 PM	Abstract	373 - Amantadine Alleviates the Motor and Dopamine Receptor Changes in a Levodopa-Induced Dyskinesia (LID) Model of C. elegans
08:30 AM - 07:00 PM	Abstract	374 - Effect of Fatigue on Physical versus Mental Health-Related Quality of Life in Parkinson Disease Laura Brosbe, DO
08:30 AM - 07:00 PM	Abstract	375 - Olfaction, Attention Performance, and Response Speed Variability in Early Parkinson’s Disease
08:30 AM - 07:00 PM	Abstract	376 - Weight Changes in PD Patients Post-DBS: A Look at the Factors Involved
08:30 AM - 07:00 PM	Abstract	377 - Advanced Therapy Referral in Parkinson’s Disease Using Wearable Sensors Dustin A. Heldman, PhD
08:30 AM - 07:00 PM	Abstract	378 - Can Transcranial Magnetic Stimulation Improve Axial Symptoms in Parkinson’s Disease? Milton Biagioni, MD
08:30 AM - 07:00 PM	Abstract	379 - Comparing Effects of Age of Onset and Disease Duration in Parkinson Disease Karl J. Maki, MD
08:30 AM - 07:00 PM	Abstract	380 - Success of Targeting Rationale in Deep Brain Stimulation for Parkinson’s Disease Andra Farcas
08:30 AM - 07:00 PM	Abstract	381 - Loss-of-Function Mutations of Cyclic Nucleotide Gated (CNG) Ion Channels Protect Dopaminergic Neurodegeneration and Loss of Motor Activity in C. elegans Overexpressing Human α-Synuclein
08:30 AM - 07:00 PM	Abstract	382 - Activation of Chaperone-Mediated Autophagy Prevents Accumulation of Oligomeric Alpha-Synuclein in LRRK2 R1441G Knockin Mice of Parkinson’s Disease Shu Leong Ho, MD, FAAN
08:30 AM - 07:00 PM	Abstract	383 - Statin Usage in Parkinson’s Disease in Relation to Vascular Comorbidities and Risk Factors
08:30 AM - 07:00 PM	Abstract	384 - Repeat Size and X-Inactivation in the Clinical Phenotype of Fragile X Premutation Carrier Sisters: A Familial Case Series Erin Robertson-Dick
08:30 AM - 07:00 PM	Abstract	385 - The Role of Antisense FMR1 in Fragile X-Associated Tremor/Ataxia Syndrome Padmaja Vittal, MD, MS
08:30 AM - 07:00 PM	Abstract	386 - Predictors of Cognitive Decline in FXTAS Joash T. Lazarus, MD
08:30 AM - 07:00 PM	Abstract	387 - Long-Term Effect of Epoetin Alfa on Clinical and Biochemical Markers in Friedreich Ataxia Francesco Sacca, MD, FAAN
08:30 AM - 07:00 PM	Abstract	388 - EPI-743 for Friedreichs Ataxia Patients with Point Mutations Kelly Sullivan, PhD
08:30 AM - 07:00 PM	Abstract	389 - Difficulties in Making an Antemortem Diagnosis of Sporadic Fatal Insomnia, a Rare Form of Sporadic Prion Disease Paul R. Lee, MD, PhD
08:30 AM - 07:00 PM	Abstract	390 - Co-Existence of Novel KIF1A Mutation (SPG30) and Intronic Expansion of BEAN (SCA31) in a Family: Clinical and Genetic Characterization Arika Hasegawa
08:30 AM - 07:00 PM	Abstract	391 - Novel CACNB4 Variant Associated with a Case of Progressive Ataxia Alexandra J. Sequeira, MD
08:30 AM - 07:00 PM	Abstract	392 - X-linked spinocerebellar ataxia (SCA) type 1A: a novel late onset phenotype of the ATP2B3 mutation Christopher D. Stephen, MB ChB, FRCP, MSc, SM
08:30 AM - 07:00 PM	Abstract	393 - Neuropathology of Parkinsonism in Spinocerebellar Ataxia type 6: a case report Diviya Kaul, MD
08:30 AM - 07:00 PM	Abstract	394 - A Mutation Causing Reduced BK Channel Activity Leads to Cognitive Inpairment and Progressive Cerebellar Ataxia Julia E. Staisch, MD
08:30 AM - 07:00 PM	Abstract	395 - 49 Year Old Male with Rapidly Progressive Cerebellar Ataxia Secondary to Non-Paraneoplastic Voltage-Gated Calcium Channel Antibodies (VGCC): Case Report Shnehal Patel, MD
08:30 AM - 07:00 PM	Abstract	396 - Prolonged Cerebellar Syndrome After Legionnaire’s Disease Brandon R. Barton, MD, FAAN
08:30 AM - 07:00 PM	Abstract	397 - The Broadening Clinical Spectrum Associated with ATP1A3 Mutations Inge Meijer, MD, PhD
08:30 AM - 07:00 PM	Abstract	398 - Likely Underrecognized Mosaicism in Genetic Disease: High Frequency of Mosaic Mutations in ADCY5-Related Dyskinesia Dong-Hui Chen, MD, PhD
08:30 AM - 07:00 PM	Abstract	399 - Clinical Characteristics and Natural History of Oromandibular and Lingual Dystonia Laura M. Scorr, MD
08:30 AM - 07:00 PM	Abstract	400 - Functional dystonia: 10-year experience in a specialized dystonia clinic Christopher D. Stephen, MB ChB, FRCP, MSc, SM
08:30 AM - 07:00 PM	Abstract	402 - Preclinical Model of Parkinson’s Disease Using Circuit Specific Optogenetics

Faculty Disclosures
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ�� (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Arun Asha Kalra, MD, FAAN	No disclosure on file
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Tatsuro M. Mutoh, MD, PhD, FAAN	Dr. Mutoh has nothing to disclose.
Joohi Jimenez Shahed, MD, FAAN	Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with ��ɫ��. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
Max J. Hilz, MD, PhD, FAAN	Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Ricardo E. Madrid, MD, FAAN	No disclosure on file
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Brigitte Wildemann, MD	The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand.
David C. Spencer, MD, FAAN	Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuiticals. Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. The institution of Dr. Spencer has received research support from NIH. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative ��ɫ�� Concepts.
Daniel Kaufer, MD, FAAN	No disclosure on file
John C. Morris, MD, FAAN	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Antonio M. Omuro, MD, FAAN	Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo.
Kathryn A. Davis, MD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals/Jazz Pharmaceuticals. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UNEEG. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Davis has received research support from Eisai. The institution of Dr. Davis has received research support from Liminal. Dr. Davis has received publishing royalties from a publication relating to health care.
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Andreas J. Plaitakis, MD	No disclosure on file
Peter Hedera, MD	Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Hedera has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for University of Louisville.
Peter Sillevis Smitt, MD	The institution of Dr. Sillevis Smitt has received research support from Euroimmun. Dr. Sillevis Smitt has received intellectual property interests from a discovery or technology relating to health care.
Maarten J. Titulaer, MD, PhD	The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received intellectual property interests from a discovery or technology relating to health care. Dr. Titulaer has received publishing royalties from a publication relating to health care.
Shafali Jeste, MD, FAAN	Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance.
Roy L. Freeman, MD	Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron.
Silva Markovic-Plese, MD, FAAN	Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Thomas D. Bird, MD, FAAN	Dr. Bird has nothing to disclose.
Phillip D. Swanson, MD	No disclosure on file
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Deborah H. Hall, MD, PhD, FAAN	Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Katya Rascovsky	No disclosure on file
Kenneth H. Fischbeck, MD, FAAN	Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to AAN interests or activities.
Angus Wilfong, MD	No disclosure on file
Jose C. Navarro, MD	No disclosure on file
Minas Tzagournissakis, MD	No disclosure on file
Elizabeth M. Berry-Kravis, MD, PhD	The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Zevra. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with ��ɫ��. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing ��ɫ��, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Remi W. Bouchard, MD	No disclosure on file
Jorge L. Juncos, MD	No disclosure on file
John T. Kissel, MD, FAAN	Dr. Kissel has nothing to disclose.
Alfred J. Spiro, MD, FAAN	No disclosure on file
Lionel Carmant, MD	No disclosure on file
Clifton L. Gooch, MD, FAAN	Dr. Gooch has received publishing royalties from a publication relating to health care. Dr. Gooch has received publishing royalties from a publication relating to health care.
Shinji Ohara, MD, FAAN	No disclosure on file
Michael P. Collins, MD	Dr. Collins has nothing to disclose.
Luca Durelli, MD	No disclosure on file
Marie Vidailhet, MD, PhD	No disclosure on file
Gregory Fuller, MD, PhD	Dr. Fuller has nothing to disclose.
Charles C. Flippen II, MD, FAAN	Dr. Flippen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Carelon. Dr. Flippen has a non-compensated relationship as a committee member with American Headache Society that is relevant to AAN interests or activities. Dr. Flippen has a non-compensated relationship as a committee/task force member with American Neurological Association that is relevant to AAN interests or activities.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Juan Carlos Gomez Esteban, MD	Dr. Gomez Esteban has nothing to disclose.
Michael B. Russell	No disclosure on file
Anita Datta, MD	No disclosure on file
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Martha Morrell, MD, FAAN	Dr. Morrell has received personal compensation for serving as an employee of NeuroPace. Dr. Morrell has stock in NeuroPace. The institution of Dr. Morrell has received research support from National Institutes of Health.
James B. Leverenz, MD, FAAN	Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Shrikant Mishra, MD	Dr. Mishra has nothing to disclose.
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Stephan Zuchner, MD, FAAN	Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Lloyd H. Kasper, MD	No disclosure on file
David A. Bennett, MD	Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Elijah Stommel, MD, FAAN	Dr. Stommel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Suslick Attorney. The institution of Dr. Stommel has received research support from CDC.
Alison Goate, PhD	No disclosure on file
James M. Stankiewicz, MD, FAAN	Dr. Stankiewicz has received personal compensation for serving as an employee of Novartis.
Wolfgang Singer, MD, FAAN	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Mark Edwards, MBBS	Dr. Edwards has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Edwards has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Edwards has stock in Brain and Mind Ltd. The institution of Dr. Edwards has received research support from NIHR. Dr. Edwards has received publishing royalties from a publication relating to health care.
Samir Belal, MD	No disclosure on file
Howard Feldman, MD, FAAN	The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Allyx Pharmaceuticals. The institution of Dr. Feldman has received research support from Canadian Institutes of Health Research . Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Royal Society of Canada that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Banner Health that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter, Manuscript Author with University of British Columbia that is relevant to AAN interests or activities.
Vera Novak, MD	No disclosure on file
Patricia Limousin, MD	No disclosure on file
Amie L. Hiller, MD	The institution of Dr. Hiller has received research support from Admas Pharmaceuticals.
Giancarlo Logroscino, MD, PhD, FAAN	Dr. Logroscino has nothing to disclose.
Christopher M. DeGiorgio, MD, FAAN	Dr. DeGiorgio has received intellectual property interests from a discovery or technology relating to health care.
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Claudia A. Chiriboga, MD, FAAN	Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Chiriboga has received research support from Roche. The institution of Dr. Chiriboga has received research support from Avexis/Novartis. The institution of Dr. Chiriboga has received research support from Biogen. The institution of Dr. Chiriboga has received research support from NIH. The institution of Dr. Chiriboga has received research support from Biohaven. The institution of Dr. Chiriboga has received research support from Genentec. Dr. Chiriboga has received publishing royalties from a publication relating to health care.
Mary B. Connolly, MD	Dr. Connolly has nothing to disclose.
Antonio Bertolotto, MD, FAAN	Dr. Bertolotto has nothing to disclose.
Weihua Zhao, MD	No disclosure on file
	No disclosure on file
Andrea Boon, MD	Dr. Boon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HPE cosmetics .
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Peter T. Fox, MD	No disclosure on file
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Rachel J. Saunders-Pullman, MD	The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Douglas S. Goodin, MD	No disclosure on file
Stewart A. Factor, DO, FAAN	Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Katherine L. Possin, PhD	Dr. Possin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ClearView Healthcare Partners. The institution of Dr. Possin has received research support from Quest Diagnostics. The institution of Dr. Possin has received research support from NIH. The institution of Dr. Possin has received research support from The Global Brain Health Institute. The institution of Dr. Possin has received research support from The Rainwater Foundation.
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Mark S. Quigg, MD	Dr. Quigg has received personal compensation for serving as an employee of Natus. Dr. Quigg has received personal compensation for serving as an employee of Neurocrine. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Finnigen and Harrison. Dr. Quigg has received research support from NIH. Dr. Quigg has received publishing royalties from a publication relating to health care.
David N. Herrmann, MD, FAAN	Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Maria J. Molnar, MD, PhD	Dr. Molnar has nothing to disclose.
Luis Salazar	No disclosure on file
Jianhua Yan, PhD	No disclosure on file
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Barbara Bumstead, NP	Ms. Bumstead has nothing to disclose.
Luisa Maria Villar Guimerans, MD	No disclosure on file
Christopher H. Gibbons, MD, FAAN	Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has or had stock in CND Life Sciences.Dr. Gibbons has received publishing royalties from a publication relating to health care.
Jeremy D. Schmahmann, MD, FAAN	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Salvatore DiMauro, MD	No disclosure on file
Timothy K. Vartanian, MD, PhD	Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Vartanian has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Vartanian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tisch MS Center. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Sarah Song, MD, MPH, FAAN	Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN.
Nicholas S. Abend, MD, FAAN	Dr. Abend has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Epilepsy Foundation. The institution of Dr. Abend has received research support from NIH. The institution of Dr. Abend has received research support from PCORI. Dr. Abend has received publishing royalties from a publication relating to health care.
Gil I. Wolfe, MD, FAAN	Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Nathan B. Fountain, MD, FAAN	Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Coda. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BrainStorm. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shackleford. Dr. Fountain has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Acumen. Dr. Fountain has stock in Hexokine.
Gary W. Small, MD	No disclosure on file
Marjo Van Der Knaap, MD, PhD	The institution of Marjo Van Der Knaap, MD, PhD has received research support from Calico. The institution of Marjo Van Der Knaap, MD, PhD has received research support from Ionis.
Victoria S. Wong, MD, FAAN	No disclosure on file
Shefali Karkare, MD	Dr. Karkare has nothing to disclose.
Brian K. Kaspar, PhD	No disclosure on file
James Sheridan, PhD	No disclosure on file
Laurel J. Cherian, MD, FAAN	The institution of Dr. Cherian has received research support from NIH.
Andrew J. Kornberg, MD	Dr. Kornberg has nothing to disclose.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Nancy M. Nealon, MD	Dr. Nealon has nothing to disclose.
Gregory Krauss, MD	Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Basil T. Darras, MD	The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Antonio Daniele	No disclosure on file
Jose F. Tellez Zenteno, MD, PhD, FRCP	No disclosure on file
Emily Mirro	No disclosure on file
Nadia Tenenbaum, MD	Dr. Tenenbaum has received personal compensation for serving as an employee of EMS Serono. Dr. Tenenbaum has stock in EMS Serono.
Atsushi Iwata, MD	No disclosure on file
Mohammad Ikram	The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc.
Stephen M. Newman, MD	Dr. Newman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme . Dr. Newman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen.
Rolando J. Giannaula, MD	No disclosure on file
Samuel F. Hunter, MD, PhD	The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
Shoji Tsuji, MD, PhD	The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Todd D. Levine, MD	Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Lora L. Clawson, MSN, CRNP	No disclosure on file
Soe S. Mar, MD, FAAN	The institution of Dr. Mar has received research support from NIH.
Naomi Lubarr, MD	Dr. Lubarr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for applied therapeutics.
Warren B. Zigman, PhD	No disclosure on file
Timothy Cunniff, PharmD	Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Danielle M. Andrade, MD	The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities.
Barbara C. Jobst, MD, PhD, FAAN	Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC.
Mark Gudesblatt, MD	The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Albert C. Ludolph, MD	Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Ludolph has received personal compensation in the range of $0-$499 for serving as a Consultant for FundaMental Pharma . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biologix FZCo.. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon.
Jonathan S. Katz, MD	Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Calico. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Griffols. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Adeline Vanderver, MD, FAAN	An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Steven Frucht, MD	Dr. Frucht has nothing to disclose.
John W. Day, MD, PhD	Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PepGen. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epirium Bio. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Astellas Pharma. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. The institution of Dr. Day has received research support from AMO Pharma. The institution of Dr. Day has received research support from AnnJi. Dr. Day has received research support from CureSMA. The institution of Dr. Day has received research support from Muscular Dystrophy Association. The institution of Dr. Day has received research support from Ionis Pharmaceuticals. The institution of Dr. Day has received research support from NMD Pharma. The institution of Dr. Day has received research support from SMA Foundation. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Paul Matthews, MD	No disclosure on file
Nicholas J. Maragakis, MD, FAAN	Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UptoDate. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharmaceuticals. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. An immediate family member of Dr. Maragakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Basketball Association. Dr. Maragakis has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Akava. An immediate family member of Dr. Maragakis has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Johns Hopkins Howard County Medical Center. Dr. Maragakis has stock in Akava. The institution of Dr. Maragakis has received research support from NIH/NINDS. The institution of Dr. Maragakis has received research support from Department of Defense. The institution of Dr. Maragakis has received research support from Maryland Stem Cell Research Fund. Dr. Maragakis has received intellectual property interests from a discovery or technology relating to health care.
Gihan Tennekoon, MD	No disclosure on file
Juan C. Maiques, MD	No disclosure on file
Elena Bravver, MD	No disclosure on file
Matthew Troester, DO	No disclosure on file
Ann Gruber-Baldini	No disclosure on file
James Conners, MD	The institution of Dr. Conners has received research support from nih.
Rivka Sachdev, MD	No disclosure on file
Chunfeng Liu	No disclosure on file
Frank Bennett, PhD	No disclosure on file
Nicholas Schwab	The institution of Nicholas Schwab has received research support from Biogen. The institution of Nicholas Schwab has received research support from Roche.
Panayiotis Mitsias, MD	The institution of Dr. Mitsias has received research support from European Union.
David Robertson, MD	No disclosure on file
Mark Tarnopolsky, MD, PhD, FRCP	Dr. Tarnopolsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Tarnopolsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reneo . Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Tarnopolsky has stock in Synaptive Medical. Dr. Tarnopolsky has stock in CloudDx. The institution of Dr. Tarnopolsky has received research support from Canadian Institute for Health Research. Dr. Tarnopolsky has received intellectual property interests from a discovery or technology relating to health care.
Berge A. Minassian, MD	Dr. Minassian has nothing to disclose.
Vivien H. Lee, MD, FAAN	Dr. Lee has nothing to disclose.
Hos C. Loftus, MD	No disclosure on file
Hidekazu Tomimoto, MD	No disclosure on file
Leslie Ferguson, MD	No disclosure on file
Harald Murck	No disclosure on file
Pearl K. Jones, MD	No disclosure on file
Maria del Pilar Guillermo Prieto Eibl, MD	Dr. Guillermo Prieto Eibl has nothing to disclose.
Gregory L. Barkley, MD	No disclosure on file
John E. Greenlee, MD, FAAN	Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Bradley C. Hiner, MD	No disclosure on file
April L. McVey, MD	No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Leonard van den Berg, MD	The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Patrick M. Grogan, MD, FAAN	No disclosure on file
Kazuko Hasegawa, MD	Dr. Hasegawa has nothing to disclose.
Matthew P. Wicklund, MD, FAAN	Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Dr. Wicklund has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. The institution of Dr. Wicklund has received research support from Orphazyme. The institution of Dr. Wicklund has received research support from Muscular Dystrophy Association. The institution of Dr. Wicklund has received research support from Coalition to Cure Calpain 3. The institution of Dr. Wicklund has received research support from Sarepta Therapeutics. The institution of Dr. Wicklund has received research support from ML Bio. The institution of Dr. Wicklund has received research support from Alexion. The institution of Dr. Wicklund has received research support from Acceleron. The institution of Dr. Wicklund has received research support from Edgewise. The institution of Dr. Wicklund has received research support from Fulcrum. The institution of Dr. Wicklund has received research support from Roche-Genentech. The institution of Dr. Wicklund has received research support from Avidity. Dr. Wicklund has received research support from Harmony Bioscience.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Joanna C. Jen, MD, PhD	Dr. Jen has nothing to disclose.
John Alam	No disclosure on file
Jens Schmidt, MD, FAAN	Dr. Schmidt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring and UCB. Dr. Schmidt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring and LFB. Dr. Schmidt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Schmidt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Schmidt has received research support from Kezar, Novartis and AFM.
Johannes Jakobsen, MD, DMSci	The institution of Dr. Jakobsen has received research support from TAKEDA. Dr. Jakobsen has received publishing royalties from a publication relating to health care. Dr. Jakobsen has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with Danish Medicine Counsil.
Liang Lu, MD, FAAN	Dr. Lu has nothing to disclose.
Bruce R. Korf, MD	Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Pharmaceuticals. Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Healx. Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Recursion. Dr. Korf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genome Medical. Dr. Korf has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Infixion. Dr. Korf has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Human Genetics. Dr. Korf has stock in Genome Medical. The institution of Dr. Korf has received research support from NIH. The institution of Dr. Korf has received research support from Department of Defense. The institution of Dr. Korf has received research support from Children's Tumor Foundation. Dr. Korf has received publishing royalties from a publication relating to health care. Dr. Korf has received publishing royalties from a publication relating to health care. Dr. Korf has received publishing royalties from a publication relating to health care.
Stuart H. Isaacson, MD, FAAN	The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
James A. Mastrianni, MD, PhD	Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Mastrianni has received research support from Brain Research Foundation.
Howard J. Rosen, MD	Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Alan Ettinger, MD, FAAN	No disclosure on file
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Ramon C. Leiguarda, MD	No disclosure on file
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Mark E. Landau, MD, FAAN	No disclosure on file
Michael Wong, MD, PhD	No disclosure on file
Ingelise Christiansen, PhD	No disclosure on file
Masahito Mihara, MD, PhD	No disclosure on file
Alessandro Filla, MD, FAAN	No disclosure on file
Thyagarajan Subramanian, MD, MBBS, FAAN	Dr. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Subramanian has received research support from National Institutes of Health. The institution of Dr. Subramanian has received research support from Ann and Phillip Gladfetler III Foundation. The institution of Dr. Subramanian has received research support from Department of Defense . Dr. Subramanian has received publishing royalties from a publication relating to health care. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Institutes of Health.
Mary Kay Floeter, MD, PhD	No disclosure on file
Cristina M. Ramo, MD	Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANDOZ. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ramo has received research support from HORIZON-2020. The institution of Dr. Ramo has received research support from fis (SPANISH GOVERNMENT). The institution of Dr. Ramo has received research support from BIOGEN. The institution of Dr. Ramo has received research support from MERCK. The institution of Dr. Ramo has received research support from ALMIRALL. The institution of Dr. Ramo has received research support from NOVARTIS. The institution of Dr. Ramo has received research support from RICORS (Spanish Government). The institution of Dr. Ramo has received research support from ROCHE. Dr. Ramo has received publishing royalties from a publication relating to health care.
Carlo Casali	No disclosure on file
Bryan Traynor, MD	The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care.
Brent P. Goodman, MD	Dr. Goodman has nothing to disclose.
Florian Eichler, MD	An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Fenna T. Phibbs, MD	No disclosure on file
Emily J. Gilmore, MD	Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Henrik Zetterberg	Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Lyle Ostrow, MD, PhD	The institution of Dr. Ostrow has received research support from NINDS. The institution of Dr. Ostrow has received research support from CDC National ALS Registry (ATSDR).
Scheherazade Le, MD	Dr. Le has nothing to disclose.
Charles Cho	No disclosure on file
Egemen Idiman, MD	No disclosure on file
Faisal Fecto, MD, PhD	The institution of Dr. Fecto has received research support from NINDS.
Giorgia Puorro	Giorgia Puorro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Elma Research. Giorgia Puorro has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion.
Elie Naddaf, MD	Dr. Naddaf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Expert Connect. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Klick, Inc. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcellx. The institution of Dr. Naddaf has received research support from NIAMS. The institution of Dr. Naddaf has received research support from Fulcrum therapeutics. The institution of Dr. Naddaf has received research support from Abcuro. The institution of Dr. Naddaf has received research support from Cabaletta . The institution of Dr. Naddaf has received research support from Arcellx.
Joash T. Lazarus, MD	Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Lazarus has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers squib. Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for USWM. Dr. Lazarus has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for arcadia. Dr. Lazarus has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for acorda. Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for allergan. The institution of Dr. Lazarus has received research support from Genentech.
Roopali Ghandi	No disclosure on file
Maria Rodriguez Rodriguez, MD	Maria Rodriguez Rodriguez, MD has nothing to disclose.
Charles F. Spurlock III, PhD	Dr. Spurlock has received personal compensation for serving as an employee of Decode Health. Dr. Spurlock has received personal compensation for serving as an employee of New York University. Dr. Spurlock has received personal compensation for serving as an employee of IQuity Labs. Dr. Spurlock has stock in Decode Health. Dr. Spurlock has stock in IQuity Labs. The institution of Dr. Spurlock has received research support from National Institutes of Health.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Myeong-Kyu Kim	No disclosure on file
Cleanthe Spanaki, MD, PhD	The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PHARMABIDE/SPECIFAR-TEVA. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALLERGAN. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK SERONO. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ITF. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SPECIFAR/TEVA. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SPECIFAR/TEVA. The institution of Dr. Spanaki has received research support from ABBVIE.
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Priscilla C. Russo	No disclosure on file
Heather Gordish-Dressman	Heather Gordish-Dressman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AGADA Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TRiNDS, LLC. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Statistical reviewer with TREAT-NMD TACT Committee.
Synphen Wu, MD, PhD	Dr. Wu has nothing to disclose.
Alan Guberman, MD	No disclosure on file
Wim L. Robberecht, MD, PhD	No disclosure on file
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Peter H. King, MD	The institution of Dr. King has received research support from Department of Veterans Affairs. The institution of Dr. King has received research support from NIH.
Philippe Couratier, PhD	Dr. Couratier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Couratier has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Couratier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier .
Esther Cubo Delgado, MD, PhD, FAAN	Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Dong-wha Kang, MD	No disclosure on file
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Marianna V. Spanaki-Varelas, MD, PhD	Dr. Spanaki-Varelas has received personal compensation in the range of $500-$4,999 for serving as a RUC ADVISOR with AAN .
Catherine Lomen-Hoerth, MD, PhD, FAAN	Dr. Lomen-Hoerth has nothing to disclose.
Mark S. Freedman, MD, FAAN	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Michael H. Kohrman, MD	No disclosure on file
Beomseok Jeon, MD	Dr. Jeon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Jeon has received research support from peptron. The institution of Dr. Jeon has received research support from zemvax & kael. Dr. Jeon has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Aspen Neuroscience.
Ahm M. Huq, MBBS, PhD	Dr. Huq has nothing to disclose.
Thomas C. Chelimsky, MD	Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Proctor & Gamble. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Various Legal Firms. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Legal Firms. Dr. Chelimsky has received stock or an ownership interest from PainSTakers, LLC. The institution of Dr. Chelimsky has received research support from NIDDK. The institution of Dr. Chelimsky has received research support from Advancing a Healthier Wisconsin.
Christopher Gomez, MD, PhD	Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
PHILLIP L. PEARL, MD, FAAN	Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care.
Raphael Schiffmann, MD, FAAN	No disclosure on file
Wim Van Paesschen, MD	No disclosure on file
Christine A. De Meulemeester, MD	No disclosure on file
Kunihiko Asakura, MD, PhD	No disclosure on file
Pierre-Marie Preux, MD	No disclosure on file
Philip De Jager, MD, PhD	Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
Jaime Imitola, MD, FAAN	The institution of Dr. Imitola has received research support from Genentech. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
Laura Herbelin	No disclosure on file
Jens Kuhle, MD	Dr. Kuhle has nothing to disclose.
Fatema J. Serajee, MBBS	Dr. Serajee has nothing to disclose.
Anna Schubart	No disclosure on file
Samuel Lapalme-Remis, MD	Dr. Lapalme-Remis has nothing to disclose.
Timothy L. Vollmer, MD, FAAN	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Jaime R. Lopez, MD	An immediate family member of Dr. Lopez has received personal compensation for serving as an employee of AbbVie. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Lopez has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical-legal consulting.
Seung Hun Oh, MD	No disclosure on file
Duarte G. Machado, MD, FAAN	Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
De-Hyung Lee, MD	No disclosure on file
Ningshan Wang, MD, PhD	Dr. Wang has nothing to disclose.
Paul Wirtz, MD, PhD	No disclosure on file
Sanjeeva R. Onteddu, MD, FAAN	Dr. Onteddu has nothing to disclose.
Shannon M. DiCarlo, MD, FAAN	Dr. DiCarlo has nothing to disclose.
Christina Sundal, MD	Dr. Sundal has nothing to disclose.
Shalin D. Shah, MD	Dr. Shah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eris.
Jose Antonio Cortes Laino, MD	No disclosure on file
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
David S. Saperstein, MD	No disclosure on file
Stanley H. Appel, MD, FAAN	Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Darryl C. De Vivo, MD, FAAN	Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Richard S. Finkel, MD, FAAN	Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
Ericka P. Greene, MD, FAAN	Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Abraham & Watkins Texas Law Firm. The institution of Dr. Greene has received research support from National Science Foundaton .
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Claudia F. Lucchinetti, MD, FAAN	The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Laurie J. Ozelius, PhD	The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Richard S. Nicholas, FRCP	Dr. Nicholas has nothing to disclose.
Lara W. Katzin, MD	Dr. Katzin has nothing to disclose.
Donna C. Graves, MD, FAAN	Dr. Graves has nothing to disclose.
Denise I. Campagnolo, MD, MS	Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Inge Meijer, MD, PhD	Dr. Meijer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Dr. Meijer has received intellectual property interests from a discovery or technology relating to health care.
Shunichi Homma	No disclosure on file
Tai-Seung Nam, MD	No disclosure on file
Manuel Seijo-Martinez, MD, PhD, FAAN	No disclosure on file
Albert Hofman, MD, PhD	No disclosure on file
H. A. Jinnah, MD, PhD, FAAN	Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Seung-Han Suk, MD	No disclosure on file
Tanja D. Kuhlmann, MD	No disclosure on file
Guillermo Punzo Bravo, MD, PhD	No disclosure on file
Jun Shimizu, MD, PhD	No disclosure on file
Robert Stern, PhD	Robert Stern, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Robert Stern, PhD has received research support from Eisai. The institution of Robert Stern, PhD has received research support from Lilly. The institution of Robert Stern, PhD has received research support from ATRI/NIA. Robert Stern, PhD has received publishing royalties from a publication relating to health care. Robert Stern, PhD has a non-compensated relationship as a Member with NFLPA Mackey-White Committee that is relevant to AAN interests or activities.
Edoardo Malfatti, MD	Dr. Malfatti has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark therapeutics. Dr. Malfatti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from Spark Therapeutics. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from ANR.
John M. Ringman, MD, FAAN	The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Jacqueline Bernard, MD, FAAN	Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2ND MD. Dr. Bernard has received publishing royalties from a publication relating to health care.
Jan L. De Bleecker, MD, PhD, FAAN	Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro.
Manuel Comabella Lopez, MD	No disclosure on file
Claudia Cristina F. Vasconcelos, PhD	No disclosure on file
Liana Apostolova, MD, FAAN	Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for siemens. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. Dr. Apostolova has a non-compensated relationship as a advisor with FDA that is relevant to AAN interests or activities.
Richard K. Olney, MD	No disclosure on file
Steven P. Sparagana, MD, FAAN	Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nobelpharma. The institution of Dr. Sparagana has received research support from Greenwich Biosciences. The institution of Dr. Sparagana has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sparagana has received research support from Novartis. Dr. Sparagana has a non-compensated relationship as a Professional Advisory Board Member, committee member with Tuberous Sclerosis Alliance that is relevant to AAN interests or activities.
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Iscia Lopes-Cendes, MD, PhD	No disclosure on file
Catherine Lubetzki	Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK SERONO. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REWIND.
Jun Li, MD, PhD, FAAN	The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
Ettore Beghi, MD, FAAN	No disclosure on file
John R. Rinker II, MD, BA	Dr. Rinker has nothing to disclose.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Brandon R. Barton, MD, FAAN	Dr. Barton has nothing to disclose.
Kenkichi Nozaki, MD	No disclosure on file
Darcy Krueger, MD	Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NobelPharma USA. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RegenxBio. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwich Biosciences. The institution of Dr. Krueger has received research support from Greenwich Bioscience. The institution of Dr. Krueger has received research support from Marinus Pharmaceuticals. The institution of Dr. Krueger has received research support from National Institutes of Health. The institution of Dr. Krueger has received research support from Food and Drug Administration. The institution of Dr. Krueger has received research support from TSC Alliance.
Violaine K. Harris, PhD	No disclosure on file
Feza Deymeer, MD	No disclosure on file
Joseph Giuffrida, PhD	No disclosure on file
Dennis W. Dickson, MD	Dr. Dickson has nothing to disclose.
Rujuta B. Wilson, MD	Dr. Wilson has nothing to disclose.
Giovanni Meola, MD, FAAN	No disclosure on file
Jan O. Aasly, MD, PhD	No disclosure on file
Afshin A. Divani, PhD	The institution of Dr. Divani has received research support from Department of Defense.
Sinead Jordan	Sinead Jordan has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Idec.
Pedro Rosa Neto, MD, PhD	Dr. Rosa Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk.
Chiara Pane, MD	Dr. Pane has nothing to disclose.
Kesavamurthy Bhanu, MD	No disclosure on file
Sandra L. Cook, RN	No disclosure on file
Nicholas Sterling	No disclosure on file
Peter A. LeWitt, MD	Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Joseph J. Higgins, MD, FAAN	No disclosure on file
Theresa A. Zesiewicz, MD	Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Robert Laforce, Jr., MD, PhD	Dr. Laforce has nothing to disclose.
Stephen A. McGuire, MD, FAAN	No disclosure on file
Subramaniam Sriram, MD	Dr. Sriram has nothing to disclose.
Camilo Toro, MD, FAAN	Dr. Toro has received personal compensation in the range of $100,000-$499,999 for serving as a TORO with NIH/IRP.
Jeffrey D. Rothstein, MD, PhD	Dr. Rothstein has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept Therapeutics. Dr. Rothstein has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceuticasl. Dr. Rothstein has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ALS Journal. The institution of Dr. Rothstein has received research support from ALSA. The institution of Dr. Rothstein has received research support from MDA. The institution of Dr. Rothstein has received research support from Target ALS. The institution of Dr. Rothstein has received research support from Maryland TEDCO. The institution of Dr. Rothstein has received research support from Dept of Defense. The institution of Dr. Rothstein has received research support from National Insitutes of Health. The institution of Dr. Rothstein has received research support from Corsalex. Dr. Rothstein has received intellectual property interests from a discovery or technology relating to health care.
Julie A. Schneider, MD, MS	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for apellis. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for National Hockey League. The institution of Dr. Schneider has received research support from NIH. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a scientific advisor with Fondation Alzheimer, France.
Merit E. Cudkowicz, MD, MSC, FAAN	Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Keith J. McAvoy, MD, FAAN	No disclosure on file
Maria Rosario Luquin Piudo, MD	No disclosure on file
Shree Pandya, DPT	No disclosure on file
Jennifer R. Friedman, MD	An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Sinopia Biosciences. An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Pet Dx. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Friedman has stock in Friedman Bioventure .
Horacio C. Kaufmann, MD, FAAN	Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioArctic. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
John K. Fink, MD	No disclosure on file
Douglas R. Jeffery, MD, PhD	No disclosure on file
Kathy Selby, MD	The institution of Dr. Selby has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Selby has received research support from Biogen . The institution of Dr. Selby has received research support from Italfarmico. The institution of Dr. Selby has received research support from Reverogen.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Brian Crum, MD	Dr. Crum has nothing to disclose.
Agnes Jani-Acsadi, MD	No disclosure on file
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Fernando D. Testai, MD, PhD, FAAN	Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Livingston, Barger, Brandt & Schroeder, L.L.P.. Dr. Testai has received publishing royalties from a publication relating to health care.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Vanda Lennon, MD, PhD	The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Susan Gauthier, DO	Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Gauthier has received research support from Genentech.
William L. Severt, MD, PhD	Dr. Severt has received personal compensation for serving as an employee of AbbVie. Dr. Severt has stock in AbbVie.
Samuel F. Berkovic, MD, FRACP	No disclosure on file
Vicki Shanker, MD, FAAN	Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Stephen J. Kolb, MD, PhD	Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Kirk R. Daffner, MD, FAAN	The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
Pankaj D. Mehta, PhD	No disclosure on file
Christopher Power, MD	Dr. Power has nothing to disclose.
Naganand Sripathi, MD	Dr. Sripathi has nothing to disclose.
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
Sat Dev Batish, PhD, FAAN	Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Katherine A. Riester, MPH	No disclosure on file
Sung-Hee Hwang	No disclosure on file
Scott Przybelski	Scott Przybelski has nothing to disclose.
Jacqueline Montes, PT, EdD, NCS	Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Wolfgang Heide, MD, FEAN	No disclosure on file
Farzad Moien Afshari, MD	No disclosure on file
Eduardo E. Benarroch, MD, FAAN	Dr. Benarroch has nothing to disclose.
Ali H. Rajput, MD, FAAN	No disclosure on file
Teepu Siddique, MD, FAAN	No disclosure on file
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ��ɫ��. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. The institution of Dr. Hirano has received research support from Astellas. The institution of Dr. Hirano has received research support from Tisento Therapeutics. The institution of Dr. Hirano has received research support from Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Abliva. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Giuseppe De Michele, MD	No disclosure on file
Yoshiaki Furukawa, MD	No disclosure on file
John H. Sladky, MD, FAAN	Dr. Sladky has nothing to disclose.
Thomas M. Aune, PhD	No disclosure on file
Matthew T. Sweney, MD	No disclosure on file
Barbara Fossati, MD	No disclosure on file
Ekokobe Fonkem, DO	Dr. Fonkem has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Fonkem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Fonkem has stock in Global Cancer Technology.
Hiroki Nariai, MD	Dr. Nariai has nothing to disclose.
Izabela Karbassi	No disclosure on file
Zaganas Ioannis, DO	No disclosure on file
Fernando Santos Pinheiro, MD	No disclosure on file
Kelly Sullivan, PhD	Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care.
Qin Li Jiang, MD	No disclosure on file
Viet Nguyen, MD	Dr. Nguyen has received personal compensation for serving as an employee of Biogen. Dr. Nguyen has stock in Biogen.
Patricia Musolino, MD, PhD	An immediate family member of Dr. Musolino has received personal compensation for serving as an employee of EMD Sorono. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inozyme Pharma. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. An immediate family member of Dr. Musolino has or had stock in 2seventy Bio. An immediate family member of Dr. Musolino has or had stock in Editas Medicine. An immediate family member of Dr. Musolino has or had stock in Generation Bio. An immediate family member of Dr. Musolino has or had stock in Beam Therapeutics. An immediate family member of Dr. Musolino has or had stock in Ebotec . An immediate family member of Dr. Musolino has or had stock in Novonordisk. An immediate family member of Dr. Musolino has or had stock in Morphosys. The institution of Dr. Musolino has received research support from National Institute of Health-NINDS-R01. The institution of Dr. Musolino has received research support from Angea Biotherapeutics. The institution of Dr. Musolino has received research support from Minoryx Pharmaceuticals. The institution of Dr. Musolino has received research support from Belanger Foundation. The institution of Dr. Musolino has received research support from Rozwat Family Foundation. The institution of Dr. Musolino has received research support from Dooley Family Foundation. Dr. Musolino has received intellectual property interests from a discovery or technology relating to health care. Dr. Musolino has received publishing royalties from a publication relating to health care.
Helmut Butzkueven, MD, MBBS	Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
David F. Black, MD	No disclosure on file
Yara D. Fragoso	Yara D. Fragoso has nothing to disclose.
Luisa H. Klotz, MD	Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Meena R. Kannan, MD	Dr. Kannan has nothing to disclose.
Murat Terzi, PhD	Dr. Terzi has nothing to disclose.
Ehud Marom	Mr. Marom has received personal compensation for serving as an employee of Mapi Pharma. Mr. Marom has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Mapi Pharma. Mr. Marom has stock in Mapi Pharma. Mr. Marom has received intellectual property interests from a discovery or technology relating to health care.
Wally V. Knezevic, MBBS, FRACP	No disclosure on file
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Joseph E. Parisi, MD	Dr. Parisi has nothing to disclose.
Nutan Sharma, MD, PhD, FAAN	Dr. Sharma has nothing to disclose.
Carlo Caltagirone	No disclosure on file
Charlene R. Hoffman-Snyder, DNP	No disclosure on file
Joel Kramer, PhD	The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Manish Modi	No disclosure on file
Nora B. Alfugham, MD	No disclosure on file
Charles Kassardjian, MD, FAAN	Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Stefan Bittner	Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
Elka Stefanova	No disclosure on file
Thomas V. Kodankandath, MD, FAAN	Dr. Kodankandath has nothing to disclose.
Christine Schuhmann	No disclosure on file
Rosa Capozzo	No disclosure on file
David Cachia, MD	Dr. Cachia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for RedHill Biopharma Ltd. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GuidePoint Global LLC. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dedham Group. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Massachusetts Neurological Society.
Emmanuel O. Sanya, MD	No disclosure on file
Alessandro S. Farias, PhD	No disclosure on file
Ammar Hussain, MD	No disclosure on file
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Daniel A. Drubach, MD, FAAN	No disclosure on file
Paul E. Greene, MD	No disclosure on file
Charles H. Tegeler, MD	Dr. Tegeler has nothing to disclose.
Jiri Vajsar, MD	Dr. Vajsar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Vajsar has received research support from CSL Behring.
Kara Jones	No disclosure on file
Betsy N. Williams, PhD	Dr. Williams has received personal compensation for serving as an employee of IQVIA.
Farida Abid, MD	No disclosure on file
Seung-Han Lee, MD, PhD	Dr. Lee has nothing to disclose.
Seema K. Tiwari-Woodruff, PhD	No disclosure on file
Letizia M. Leocani, MD	Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning.
Jacqueline Channon-Smith	No disclosure on file
Erica Selheimer, MD	No disclosure on file
Michelle Greer	No disclosure on file
Kwan Ng, MD, PhD	Dr. Ng has nothing to disclose.
Daniel Mielcarz	No disclosure on file
Marta Radaelli	Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
William Anderson	No disclosure on file
Allan M. Glanzman, PT	Mr. Glanzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Mr. Glanzman has received intellectual property interests from a discovery or technology relating to health care.
Michael K. Racke, MD	Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has or had stock in Quest Diagnostics.Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
John W. Lindsey, MD	Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Jerome Lisk, MD, MBA, MS, FAAN	The institution of Dr. Lisk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Lisk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal PHarmaceuticals. The institution of Dr. Lisk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for ADAMAS. Dr. Lisk has received intellectual property interests from a discovery or technology relating to health care.
Yedatore S. Venkatesh, MD, FAAN	Dr. Venkatesh has nothing to disclose.
Piraye Serdaroglu, MD	No disclosure on file
Chon-Haw Tsai, MD, PhD	No disclosure on file
Kevin M. Barrett, MD, FAAN	Dr. Barrett has nothing to disclose.
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Jane E. Howard, MD	No disclosure on file
Alessandro Di Rocco, MD	Dr. Di Rocco has nothing to disclose.
Felicia B. Axelrod, MD	No disclosure on file
Martin Berghoff, MD, FAAN	Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
Shailaja Gaddam, MD	No disclosure on file
Edmond Teng, MD, PhD	Dr. Teng has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Teng has received personal compensation for serving as an employee of Evidation Health. Dr. Teng has stock in F. Hoffman-La Roche. An immediate family member of Dr. Teng has stock in Evidation Health. Dr. Teng has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Teng has received intellectual property interests from a discovery or technology relating to health care.
Krai Chatamra, PhD	No disclosure on file
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Jeffrey C. McClean II, MD, FAAN	Dr. McClean has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with ��ɫ��.
Soniza Vieira A. Leon, Sr., MD, PhD	Dr. Leon has nothing to disclose.
Andrew Mammen, MD, PhD	Dr. Mammen has received research support from National Institutes of Health. The institution of an immediate family member of Dr. Mammen has received research support from National Institutes of Health. Dr. Mammen has received intellectual property interests from a discovery or technology relating to health care.
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Thomas L. Davis, MD	Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Parkinson Foundation.
Margaret A. Pericak-Vance, PhD	Dr. Pericak-Vance has nothing to disclose.
Anne Lortie, MD	No disclosure on file
Ronald Postuma, MD	Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Mustafa Sahin, MD, PhD	Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenxbio . Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Centene. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for PTEN Research. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Sahin has received research support from NIH. The institution of Dr. Sahin has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sahin has received research support from Charities Aid Foundation. The institution of Dr. Sahin has received research support from Simons Foundation Autism Research Initiative. The institution of Dr. Sahin has received research support from Aucta Pharmaceuticals . The institution of Dr. Sahin has received research support from Loulou Foundation.
Leslie H. Lee, MD, FAAN	Dr. Lee has nothing to disclose.
Hassan H. Salama, MD, PhD	No disclosure on file
Lakshmi N. Ranganathan, MD, PhD, FAAN	Dr. Ranganathan has nothing to disclose.
Rosa Rademakers, PhD	Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mayo Clinic. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Fondation. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kisick Family Foundation (FTD grant program). The institution of Rosa Rademakers, PhD has received research support from NIH. The institution of Rosa Rademakers, PhD has received research support from DOD. The institution of Rosa Rademakers, PhD has received research support from Flanders Institute for Biotechnology (VIB). The institution of Rosa Rademakers, PhD has received research support from Flanders Funds for Scientific Research.
Padmaja Vittal, MD, MS	Dr. Vittal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie Pharmaceuticals. Dr. Vittal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals .
Carolina B. Maciel, MD, MSCR, FAAN	Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health.
Donald Lee	No disclosure on file
Ian J. Sutton, PhD	Dr. Sutton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sutton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sutton has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Hugh Kearney, MD, PhD	Dr. Kearney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Thomas J. Lukas, PhD	No disclosure on file
Panos-Alexis Stathopoulos, MD	Dr. Stathopoulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. The institution of Dr. Stathopoulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Stathopoulos has received personal compensation in the range of $0-$499 for serving as a Consultant for Medicxi. Dr. Stathopoulos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VIANEX. Dr. Stathopoulos has stock in MABY. The institution of Dr. Stathopoulos has received research support from The Onassis Foundation. Dr. Stathopoulos has received personal compensation in the range of $5,000-$9,999 for serving as a Physician of Clinical Trial with Roche.
Hacer Durmus, MD	Dr. Durmus has nothing to disclose.
Xuling Lin, MD	The institution of Dr. Lin has received research support from National Health Innovation Center.
Derya Kaya	No disclosure on file
Lucas Restrepo, MD, PhD	Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
Shu Leong Ho, MD, FAAN	No disclosure on file
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Kurt Kimpinski, MD, PhD	No disclosure on file
Shyamal Mehta, MD, PhD, FAAN	Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings.
Elizabeth Gerard, MD	Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University). Dr. Gerard has received publishing royalties from a publication relating to health care.
Maiken Nedergaard, MD, DMSc	Maiken Nedergaard, MD, DMSc has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for CNS2. Maiken Nedergaard, MD, DMSc has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for CNS2.
Jeffrey M. Gelfand, MD, MS, FAAN	Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Stephan Schuele, MD, FAAN	Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Schuele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Schuele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Thomas Needham. Dr. Schuele has received research support from National Institute of Health.
Leonard Verhagen Metman, MD, PhD	Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Jonathan D. Glass, MD	Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apic Bio. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bryan Cave Leighton Paisner. The institution of Dr. Glass has received research support from NIH. The institution of Dr. Glass has received research support from ALS Assoiciation. The institution of Dr. Glass has received research support from Muscular Dystrophy Assoication.
Jose E. Cavazos, MD, PhD	Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
Charles Tilbery, MD	No disclosure on file
Michele Yang, MD	The institution of Dr. Yang has received research support from Janssen. The institution of Dr. Yang has received research support from Edgewise. The institution of Dr. Yang has received research support from ReveraGen.
David R. Beers, PhD	No disclosure on file
Emmanuel Roze, MD, PhD	Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merz. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Roze has received research support from merz. The institution of Dr. Roze has received research support from Orkyn. Dr. Roze has received research support from elivie. The institution of Dr. Roze has received research support from allergan. The institution of Dr. Roze has received research support from fondation desmarest. The institution of Dr. Roze has received research support from everpharma. Dr. Roze has received research support from AMADYS. The institution of Dr. Roze has received research support from ADCY5.org. The institution of Dr. Roze has received research support from agence nationale de la recherche. The institution of Dr. Roze has received research support from société française de médecine esthétique. The institution of Dr. Roze has received research support from dystonia medical research foundation.
Cullen M. O'Gorman, MBBS	Dr. O'Gorman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Australia Pty. An immediate family member of Dr. O'Gorman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck Australia. An immediate family member of Dr. O'Gorman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka.
Christoph Karch, MD	No disclosure on file
Joon Hyun Shin, MD	No disclosure on file
Cyrus Boelman, MD	No disclosure on file
Clement Francois	No disclosure on file
Sahawat Tantikittichaikul, MD	No disclosure on file
Andreas Schulte-Mecklenbeck	Andreas Schulte-Mecklenbeck has nothing to disclose.
Michael Hutchinson, MD	Dr. Hutchinson has nothing to disclose.
Francesco Sacca, MD, FAAN	Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Catherine M. Roe, PhD	No disclosure on file
Niall Tubridy, MD	Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Adib Tanbir	No disclosure on file
Sudhir Shah, MD, FAAN	Dr. Shah has nothing to disclose.
Christopher S. Nance, MD	No disclosure on file
Douglas M. Turnbull	No disclosure on file
Lisa Henderson	No disclosure on file
Bonnie Glanz	The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Xin Zhang	No disclosure on file
Dessa Sadovnick, PhD	No disclosure on file
Ariel L. Miller, MD, PhD	Dr. Miller has nothing to disclose.
Jorge D. Correale, MD	Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Sung-Tsang Hsieh, MD, PhD, FAAN	No disclosure on file
Hannes Vogel, MD	Dr. Vogel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Lipton Law . Dr. Vogel has received publishing royalties from a publication relating to health care.
Jeffrey Ralph, MD	No disclosure on file
Thomas J. Montine, MD, PhD	Dr. Montine has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Enable Medicine. Dr. Montine has stock in Enable Medicine. The institution of Dr. Montine has received research support from NIH. The institution of Dr. Montine has received research support from MJFF. Dr. Montine has received intellectual property interests from a discovery or technology relating to health care. Dr. Montine has received publishing royalties from a publication relating to health care.
Miho Murata	No disclosure on file
Tracy T. Batchelor, MD, MPH	Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Fuki M. Hisama, MD, FAAN	An immediate family member of Dr. Hisama has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. The institution of Dr. Hisama has received research support from UW Brotman Baty Precision Medicine Institute. The institution of Dr. Hisama has received research support from NIH/NHGRI.
Majaz Moonis, MD, FAHA, FAAN	Dr. Moonis has nothing to disclose.
Edgardo Cristiano, MD	Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Jiong Shi, MD, FAAN	Dr. Shi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Aspasia Michoulas, MD	No disclosure on file
Manish Modi, MD	Dr. Modi has nothing to disclose.
Beatriz Tijero Merino, MD	No disclosure on file
Jacob Mandel, MD	Dr. Mandel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SERVIER PHARMACEUTICALS LLC (US). Dr. Mandel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BAYER HEALTHCARE PHARMACEUTICALS (US.
Carolyn Fredericks, MD	The institution of Dr. Fredericks has received research support from Alzheimer's Association. The institution of Dr. Fredericks has received research support from National Institute on Aging.
Divya S. Nadkarni, MD	Dr. Nadkarni has nothing to disclose.
Priya Dhawan, MD	Dr. Dhawan has nothing to disclose.
Lucia Rivera Lara, MD	Dr. Rivera Lara has received personal compensation in the range of $5,000-$9,999 for serving as a expert witness with Legal firms.
Michael J. Turner, PhD	No disclosure on file
Elliot T. Dawson, MD, FAAN	Dr. Dawson has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Sonata Properites LLC. Dr. Dawson has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for 3438 Ash St LLC. Dr. Dawson has stock in Sonata Properites LLC. Dr. Dawson has stock in 816 16 1/2 St LLC. Dr. Dawson has stock in 3438 Ash St LLC.
Dimitrios I. Zafeiriou, MD, PhD	No disclosure on file
Toshiki Fujioka, MD	Dr. Fujioka has nothing to disclose.
Roelien H. Enting, MD	No disclosure on file
Angela Marsili	Angela Marsili has nothing to disclose.
Daniel Martinez-Ramirez, MD	Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Mexico. Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Mexico.
Massimiliano Copetti	No disclosure on file
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Athanasios Evangeliou	No disclosure on file
Sakhina Begum-Haque, PhD	No disclosure on file
Patrick Waters, PhD	Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. The institution of Dr. Waters has received research support from Guthy-Jackson Charitable Foundation. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care.
Sonal Mehta, MD	Dr. Mehta has nothing to disclose.
Saunder Bernes, MD	Dr. Bernes has nothing to disclose.
Vladimir S. Kostic, MD, PhD	Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of ��ɫ��, Science and Technological Development of Serbia.
Roger McKelvey, MD	No disclosure on file
Lawrence D. Morton, MD	The institution of Dr. Morton has received research support from Xenon.
Gyula Acsadi, MD, FAAN	Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Peter Novak, MD	Dr. Novak has received personal compensation for serving as an employee of Dysimmune Disease Foundation. Dr. Novak has stock in Pfeizer. Dr. Novak has stock in Moderna. Dr. Novak has stock in Novavax. Dr. Novak has stock in Editas Medicine. Dr. Novak has stock in Prothena. Dr. Novak has received publishing royalties from a publication relating to health care.
Lan Qin, MD, PhD, FAAN	No disclosure on file
Alessandra Lugaresi, MD	Dr. Lugaresi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharma. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Sqibb. Dr. Lugaresi has a non-compensated relationship as a Speaker at meetings, participant in trials with Fondazione Italiana Sclerosi Multipla that is relevant to AAN interests or activities.
John F. Ryan	No disclosure on file
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
John D. Fisk, PhD	The institution of Dr. Fisk has received research support from Canadian Institutes of Health Research. The institution of Dr. Fisk has received research support from Multiple Sclerosis Society of Canada. Dr. Fisk has received publishing royalties from a publication relating to health care.
Tanya Nelson, PharmD	No disclosure on file
Chi-Chao Chao	Chi-Chao Chao has nothing to disclose.
Jose I. Suarez, MD, FAAN	Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Idorsia. Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Mayo Clinic.
Staley A. Brod, MD	Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Joseph F. Quinn, MD, FAAN	Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Emma Ciafaloni, MD, FAAN	Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Sian D. Spacey, MD, MBBS	Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for abbvie. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartits. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lilly. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lilly. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for abbvie. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lilly.
Ging-Yuek R. Hsiung, MD, FAAN	Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Hsiung has received research support from CIHR. The institution of Dr. Hsiung has received research support from NIH. The institution of Dr. Hsiung has received research support from Eli Lilly. The institution of Dr. Hsiung has received research support from Biogen.
Aisling Ryan, PhD, MB, FRCPI	Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Benito P. Damasceno, MD, PhD	No disclosure on file
Roopali Gandhi, PhD	No disclosure on file
Paul R. Lee, MD, PhD	No disclosure on file
Pilar Mazzetti Soler, MD	No disclosure on file
Carlos Otavio Brandao, MD, PhD	No disclosure on file
Joshua L. Kamins, MD	Dr. Kamins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Kamins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. The institution of Dr. Kamins has received research support from World Boxing Council.
Massimiliano Cristofanilli, PhD	No disclosure on file
Katherine A. James, PhD	No disclosure on file
Caterina Garone	No disclosure on file
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Eugene L. Scharf, MD	The institution of Dr. Scharf has received research support from American Brain Foundation. The institution of Dr. Scharf has received research support from NIH. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Grand Rounds. Dr. Scharf has a non-compensated relationship as a Steering committee with Johnson and Johnson that is relevant to AAN interests or activities.
Xuemei Huang, MD, PhD	Dr. Huang has received personal compensation for serving as an employee of NIH. Dr. Huang has received personal compensation for serving as an employee of DoD. The institution of Dr. Huang has received research support from NIH.
Goran Rakocevic, MD, FAAN	Dr. Rakocevic has nothing to disclose.
Valerie Sim, MD, BSc	The institution of Dr. Sim has received research support from CJD Foundation. The institution of Dr. Sim has received research support from National Research Council of Canada Nanotechnology Research Centre. The institution of Dr. Sim has received research support from Alberta Innovates. The institution of Dr. Sim has received research support from Alzheimer Society of Canada. The institution of Dr. Sim has received research support from ALS Canada / Brain Canada. The institution of Dr. Sim has received research support from Results Driven Agricultural Research. Dr. Sim has received intellectual property interests from a discovery or technology relating to health care. Dr. Sim has received personal compensation in the range of $500-$4,999 for serving as a Clinical neurology consultant for human prion diseases with Public Health Agency of Canada.
Philippe Major, MD	Dr. Major has nothing to disclose.
Richard J. Nowak, MD	Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Corey Braastad, PhD	No disclosure on file
Teddy S. Youn, MD	Dr. Youn has nothing to disclose.
Marc Rosenblum	No disclosure on file
Lori Chibnik	No disclosure on file
Jessica R. Craddock, MD	No disclosure on file
Magdalini Tsolaki	No disclosure on file
Marie Y. Davis, MD, PhD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Davis has received research support from NIH NINDS. The institution of Dr. Davis has received research support from University of Washington Institute for Stem Cell and Regenerative Medicine. The institution of Dr. Davis has received research support from VA BLRD. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a study section grant reviewer with NIH. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Parkinson's Foundation.
Sha Mi, PhD	No disclosure on file
Mathula Thangarajh, MD, PhD, FAAN	Dr. Thangarajh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Thangarajh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NS Pharma.
Tamar Bacon	The institution of an immediate family member of Tamar Bacon has received research support from Novartis. The institution of an immediate family member of Tamar Bacon has received research support from Genentech. An immediate family member of Tamar Bacon has received publishing royalties from a publication relating to health care.
Jennifer Harris, MD	Dr. Harris has nothing to disclose.
Pei'En Fan, MD	No disclosure on file
Nadia Sotudeh, MD	No disclosure on file
Nazem Atassi, MD	Dr. Atassi has received personal compensation for serving as an employee of Sanofi. Dr. Atassi has stock in Sanofi.
Han-Xiang Deng, MD	Dr. Deng has nothing to disclose.
Corey McMillan, PhD	Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Gloria Von Geldern, MD, FAAN	The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Wendy E. Kaye, PhD	Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Stephane Poulin, MD	No disclosure on file
Jason Huse	No disclosure on file
Thomas L. Winder, PhD, FACMG	Dr. Winder has nothing to disclose.
Orlando G. Barsottini, MD, PhD	Dr. Barsottini has nothing to disclose.
Mark Cohen	Mark Cohen has nothing to disclose.
Pamela A. McCombe, MD	Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. The institution of Dr. McCombe has received research support from Motor Neurone Disease Resaerch Institute of Australia.
Shirley Y. Pang	Dr. Pang has nothing to disclose.
Peng Cheng Han, PhD	No disclosure on file
Louis Verret, MD	No disclosure on file
Joyce Y. Wu, MD	Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus. The institution of Dr. Wu has received research support from National Institutes of Health. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health.
Marcin P. Mycko, MD	No disclosure on file
Ralf Linker	Dr. Linker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Linker has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Linker has received research support from Novartis. The institution of Dr. Linker has received research support from Biogen.
Jennifer Lyons, MD	Dr. Lyons has received personal compensation for serving as an employee of Biogen. Dr. Lyons has received stock or an ownership interest from Biogen.
Tae Sung Lim, MD	No disclosure on file
Shingo Konno, MD	Dr. Konno has nothing to disclose.
Joseph P. Steiner, PhD	No disclosure on file
Bryan K. Woodruff, MD	The institution of Dr. Woodruff has received research support from National Institute on Aging.
Allison Wright Willis, MD	Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
Erdem Tuzun	Erdem Tuzun has nothing to disclose.
Elisabeth M. Wood, MSCGC	No disclosure on file
Shunya Nakane, MD	No disclosure on file
Susan Allen	No disclosure on file
Zsolt Illes, MD	No disclosure on file
Prasad Korlipara	No disclosure on file
Bruce Roberts, PhD	No disclosure on file
Tal Shany-Ur, PhD	No disclosure on file
Samra Vazirian, MD	No disclosure on file
Babatunde A. Ademiluyi, MD	No disclosure on file
Takumi Nakamura, MD	No disclosure on file
Jessica A. Karl, PA	No disclosure on file
Felix Bischof	Felix Bischof has nothing to disclose.
Juan Ignacio Rojas, MD	Dr. Rojas has nothing to disclose.
Amy M. Duhig, PhD	No disclosure on file
Mark Marriott, MBBS	No disclosure on file
Eugenio Pucci	No disclosure on file
Kolawole W. Wahab, MD, FAAN	Dr. Wahab has nothing to disclose.
Alexandra J. Sequeira, MD	Dr. Sequeira has nothing to disclose.
William M. Siders, PhD	No disclosure on file
Isabella L. Simone	No disclosure on file
Renato P. Munhoz, MD, PhD	Dr. Munhoz has nothing to disclose.
Min-Suk Yoon, MD	No disclosure on file
F. Rainer Von Coelln, MD	The institution of Dr. Von Coelln has received research support from University of Maryland and Maryland State Goverment. Dr. Von Coelln has received intellectual property interests from a discovery or technology relating to health care.
Jennifer S. Yokoyama, PhD	The institution of Dr. Yokoyama has received research support from NIH. The institution of Dr. Yokoyama has received research support from Alzheimer's Association . The institution of Dr. Yokoyama has received research support from Mary Oakley Foundation. The institution of Dr. Yokoyama has received research support from Alector. The institution of Dr. Yokoyama has received research support from Transposon. The institution of Dr. Yokoyama has received research support from Rainwater Charitable Foundation.
Gareth R. John	No disclosure on file
Marc Bigaud	Marc Bigaud has received personal compensation for serving as an employee of Novartis Pharma.
Ryo Ohtomo, MD	No disclosure on file
Marina Premyslova, PhD	No disclosure on file
Lan Tan	No disclosure on file
Jordan S. Dubow, MD	Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio .
Linda Huh, MD	No disclosure on file
Alfredo Damasceno, MD	No disclosure on file
Vikram Shakkottai, MD, PhD	The institution of Dr. Shakkottai has received research support from National Institutes of Health. Dr. Shakkottai has received publishing royalties from a publication relating to health care.
Cindy L. Jadoo, MD	No disclosure on file
Peter Klivenyi, PhD	No disclosure on file
Alison L. Walsh, MD	Dr. Walsh has nothing to disclose.
Guy T. Helman	No disclosure on file
Meeta Wagle Cardon, MD	Dr. Wagle Cardon has nothing to disclose.
Dobri Baldaranov, MD	No disclosure on file
Masoud Majed, MD	Dr. Majed has nothing to disclose.
Siw Johannesen, MD	No disclosure on file
Sandra D. Cassard, ScD	No disclosure on file
Santiago M. Pagano Ajolfi, Sr., MD	No disclosure on file
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Deborah Raymond	The institution of Ms. Raymond has received research support from NIH.
Jacob S. Elkins, MD	No disclosure on file
William Martens	William Martens has nothing to disclose.
Jun Hong Lee, MD	No disclosure on file
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Jennifer Whitwell, PhD	The institution of Dr. Whitwell has received research support from NIH.
Haichen Yang, MD	No disclosure on file
Joshua M. Shulman, MD, PhD, FAAN	Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation. The institution of Dr. Shulman has received research support from National Institutes of Health.
Jagan Pillai, MD, PhD, FAAN	Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Nature. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. The institution of Dr. Pillai has received research support from Alzheimer's Association. The institution of Dr. Pillai has received research support from Keep Memory Alive Foundation . The institution of Dr. Pillai has received research support from NIA. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with DOD. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with RGC Hong kong.
Edward Huey	No disclosure on file
Randall Owen	No disclosure on file
Katrina M. Pack, MD	No disclosure on file
Brittany Alperin	No disclosure on file
Laura Brosbe, DO	No disclosure on file
Martin E. Sanders, MD	No disclosure on file
Sam H. Horng, MD, PhD	The institution of Dr. Horng has received research support from National Institutes of Health . The institution of Dr. Horng has received research support from Jayne and Harvey Beker Foundation .
Martin Freed	No disclosure on file
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Rachel Couchenour, PharmD	No disclosure on file
Griselda N. Russo, MD, PhD	No disclosure on file
Ghalia Y. Alyazidi, MD	No disclosure on file
Regina Alvarenga, MD	No disclosure on file
Genevieve Bernard, MD	Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Calico. Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Orchard Therapeutics. Dr. Bernard has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for N/A. The institution of Dr. Bernard has received research support from Canadian Institutes of Health Research. The institution of Dr. Bernard has received research support from Montreal Children's Foundation. The institution of Dr. Bernard has received research support from Yaya Foundation for 4H Leukodystrophy. The institution of Dr. Bernard has received research support from Fondation Les Amis d'Elliot. The institution of Dr. Bernard has received research support from Ionis. Dr. Bernard has a non-compensated relationship as a Member of the Scientific Advisory Board with Pelizaeus-Merzbacher Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Member of the Medical and Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Chair of the Medical and Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Member of the Scientific and Clinical advisory Council with Yaya Foundation that is relevant to AAN interests or activities.
Jan H. Veldink, MD, PhD	The institution of Dr. Veldink has received research support from Biogen.
Miroslaw Brys, MD, PhD	No disclosure on file
Gerry Rowse	No disclosure on file
Cyrus P. Zabetian, MD	The institution of Dr. Zabetian has received research support from American Parkinson Disease Association. The institution of Dr. Zabetian has received research support from Department of Veterans Affairs. The institution of Dr. Zabetian has received research support from NIH. Dr. Zabetian has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Kathryn A. Chung, MD	The institution of Dr. Chung has received research support from Department of Veteran's Affairs.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Merrilee Needham, MD	Dr. Needham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for teva. Dr. Needham has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abcuro. Dr. Needham has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for sanofi aventis.
Vahid Shaygan Nejad, MD	Dr. Shaygan Nejad has nothing to disclose.
Javier Ochoa-Reparaz, PhD	No disclosure on file
Hristelina S. Ilieva, MD	The institution of Dr. Ilieva has received research support from ALSA. Dr. Ilieva has received personal compensation in the range of $0-$499 for serving as a reviewer with DOD.
Matthew Farrer, PhD	No disclosure on file
Zhenyuan Wang, PhD	Dr. Wang has nothing to disclose.
Fabio H. Porto, MD	No disclosure on file
Mohammed S. Sanjak, PhD	No disclosure on file
Gene Hung, MD	No disclosure on file
Kavita M. Grover, MD, FAAN	Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Christian Bien, MD	Dr. Bien has nothing to disclose.
Adel Alhazzani, MD, FRCPC, FAAN	Dr. Alhazzani has nothing to disclose.
Pieter Van Doorn, MD	The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grifols. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Van Doorn has received publishing royalties from a publication relating to health care.
Shawna M. Cutting, MD, FAAN	The institution of Dr. Cutting has received research support from Genentech.
Sally Dunaway, DPT	Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Dunaway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cure SMA. The institution of Dr. Dunaway has received research support from Cure SMA. The institution of Dr. Dunaway has received research support from Scholar Rock. The institution of Dr. Dunaway has received research support from Ionis Pharmaceuticals.
Kathie M. Bishop, PhD	Dr. Bishop has received personal compensation for serving as an employee of Acadia Pharmaceuticals, Inc. . Dr. Bishop has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for DTx Pharma. Dr. Bishop has stock in Acadia Pharmaceuticals, Inc..
Peter D. Creigh, MD	No disclosure on file
Jolanta Wodzinska, PhD	No disclosure on file
Valentina Emmanuele, MD, PhD	Dr. Emmanuele has nothing to disclose.
Devangi S. Mehta, PhD	No disclosure on file
Michael A. Lane, MD	Dr. Lane has nothing to disclose.
Pouya Khankhanian, MD	No disclosure on file
Cameron Brennan	Cameron Brennan has nothing to disclose.
Elizabeth A. Ng, MD, FAAP, FAANEM, FACNS, FAES	Dr. Ng has nothing to disclose.
Lakshmanan Suresh	No disclosure on file
Joanna Dojillo, MSc	No disclosure on file
James M. Meyer, PharmD	No disclosure on file
Ning Wu, MD	No disclosure on file
Brett A. Parker, MD	No disclosure on file
Alessandra Musella	No disclosure on file
Lars Markvardsen	No disclosure on file
Vibhangini Wasade, MD	No disclosure on file
Naznin Mahmood, MD	No disclosure on file
Andrew Zillgitt, DO	Dr. Zillgitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Zillgitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Zillgitt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB. Dr. Zillgitt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Zillgitt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Zillgitt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifescience.
Leonard L. Yeo, MBBS	The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC.
Tammam Dayyoub, MD	No disclosure on file
Julian C. Duda, MD	No disclosure on file
Claire Modica	An immediate family member of Claire Modica has received personal compensation for serving as an employee of Thermo Fisher Scientific. The institution of Claire Modica has received research support from Congressionally Directed Medical Research Programs. The institution of Claire Modica has received research support from Office of Naval Research.
Grace L. Liang, MD	Dr. Liang has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Liang has stock in Neurocrine Biosciences.
Norman Putzki, MD	No disclosure on file
Sarah Kremen, MD	Dr. Kremen has received publishing royalties from a publication relating to health care.
Nagaendran Kandiah, MD	No disclosure on file
David Perry, MD	The institution of Dr. Perry has received research support from NIH/NIA.
Solange Maria Das Gr Camargo, MD	No disclosure on file
Hanna Czarkowska, MD	No disclosure on file
Matthew M. Dooley, MD	No disclosure on file
Jason L. Aldred, MD, FAAN	Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan . Dr. Aldred has received personal compensation in the range of $0-$499 for serving as a Consultant for Quadralynx. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for TEVA. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US World Meds. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Arete Neuroscience, PLLC. The institution of Dr. Aldred has received research support from Biogen . The institution of Dr. Aldred has received research support from Abbvie. The institution of Dr. Aldred has received research support from Merz. The institution of Dr. Aldred has received research support from AstraZeneca. The institution of Dr. Aldred has received research support from Neurocrine. The institution of Dr. Aldred has received research support from Aptinyx. The institution of Dr. Aldred has received research support from Cerevance. The institution of Dr. Aldred has received research support from Boston Scientific . The institution of Dr. Aldred has received research support from Parkinson Foundation . The institution of Dr. Aldred has received research support from Roche. The institution of Dr. Aldred has received research support from Sage Therapeutics. The institution of Dr. Aldred has received research support from Annovis. The institution of Dr. Aldred has received research support from Biovie. The institution of Dr. Aldred has received research support from NeuroDerm. The institution of Dr. Aldred has received research support from PhotoPharma. The institution of Dr. Aldred has received research support from Lilly.
Noel Carlson, PhD	The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
J. Douglas Miles, MD, PhD, FAAN	Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
Melina Jones, PhD	No disclosure on file
Dorlan J. Kimbrough, MD	Dr. Kimbrough has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CVS.
Sol T. De Jesus, MD	Dr. De Jesus has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic Inc. Dr. De Jesus has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic Inc.
Sonja G. Schuetz, MD	Dr. Schuetz has nothing to disclose.
Duaa Jabari, MD	Dr. Jabari has nothing to disclose.
Martin Bernhard Merschhemke	Martin Bernhard Merschhemke has received personal compensation for serving as an employee of Novartis Pharma AG. Martin Bernhard Merschhemke has received stock or an ownership interest from Novartis Pharma AG.
Eduardo B. Uchoa Cavalcanti, MD, PhD, MSc, FAAN	Dr. Uchoa Cavalcanti has nothing to disclose.
Ashley Jones	No disclosure on file
Mark C. Stahl, MD, PhD	Dr. Stahl has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Stahl has stock in Avidity Biosciences.
Omar Jawdat, MD	Dr. Jawdat has nothing to disclose.
Bingbing Li	Bingbing Li has received personal compensation for serving as an employee of Novartis.
Michel Gillard, PhD	No disclosure on file
Susanta Mondal, PhD	No disclosure on file
Judith Prestifilippo, MD	No disclosure on file
Ilia Itin, MD	No disclosure on file
William J. Groh, MD	No disclosure on file
Bernard M. Uitdehaag, MD, PhD, FAAN	Dr. Uitdehaag has nothing to disclose.
Dana Ekstein, MD	No disclosure on file
Mamatha Pasnoor, MD, FAAN	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
William S. Baek, MD, FAAN	Dr. Baek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Andrew W. Varga, MD	No disclosure on file
Richard Watson, MD	No disclosure on file
Tao Xie, MD	Dr. Xie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Caremark. Dr. Xie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceutical Ltd. Dr. Xie has received research support from NIH.
James Snyder, DO	The institution of Dr. Snyder has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. The institution of Dr. Snyder has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Premier Applied Sciences. The institution of Dr. Snyder has received research support from Vizilitics inc.
Lauren M. Massimo, PhD	No disclosure on file
Gajja S. Salomons	No disclosure on file
Ludwig Aigner, PhD	No disclosure on file
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Mikael Cohen	Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Benoit Marin	No disclosure on file
Bharatendu Chandra, MD	Dr. Chandra has received intellectual property interests from a discovery or technology relating to health care.
Paul Mehta	Paul Mehta has nothing to disclose.
Nadia B. Ben Ali, PhD	No disclosure on file
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Mary M. Machulda, PhD	The institution of Dr. Machulda has received research support from NIH.
Catarina Quinzii Hirano, MD	No disclosure on file
Lisa L. Barnes, PhD	Lisa L. Barnes has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's & Dementia. The institution of Lisa L. Barnes has received research support from NIH. Lisa L. Barnes has received personal compensation in the range of $500-$4,999 for serving as a Council member with NACMHD.
Felice Sun, PhD	No disclosure on file
Susana Mederer Hengstl	No disclosure on file
Liying Cui, PhD	No disclosure on file
Christopher D. Stephen, MB ChB, FRCP, MSc, SM	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Kazuko Matsuda, MD	No disclosure on file
Elissa A. Ritt	No disclosure on file
Gharib F. Ibrahim, MD, FAAN	No disclosure on file
Catherine Tegeler	Ms. Tegeler has nothing to disclose.
Jae Hyun Park, MD	No disclosure on file
Lakshmi S. Amaravadi, PhD	No disclosure on file
Michael A. Lopez, MD, PhD	No disclosure on file
Tina Duong	Tina Duong has received personal compensation for serving as an employee of Roche. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Scholar Rock. Tina Duong has received personal compensation for serving as an employee of Genentech. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Sarepta. Tina Duong has received personal compensation for serving as an employee of Biogen. Tina Duong has received personal compensation for serving as an employee of Audentes. Tina Duong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tina Duong has received personal compensation in the range of $0-$499 for serving as a Consultant for Audentes. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Tina Duong has received research support from biogen. The institution of Tina Duong has received research support from scholar rock.
Peter McCroskery	No disclosure on file
Xiangyi Meng, PhD	Dr. Meng has nothing to disclose.
Rachel Salazar, PT	No disclosure on file
Mona Elsayed, MD	Dr. Elsayed has nothing to disclose.
Yen-Yu Chen, MD	No disclosure on file
Sharon Ash	No disclosure on file
Dustin A. Heldman, PhD	Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Glen A. Cook, Jr., MD, FAAN	Dr. Cook has stock in Aspire Biopharma. An immediate family member of Dr. Cook has stock in Aspire Biopharma.
Mark Stettner, MD	No disclosure on file
Alexis B. Shaefer, MD	Dr. Shaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Shaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Shaefer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Takeda. Dr. Shaefer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firms.
Angelo Quartarone, MD	No disclosure on file
Pariwat Thaisetthawatkul, MD, FAAN	Dr. Thaisetthawatkul has nothing to disclose.
Esra Battaloglu	Esra Battaloglu has nothing to disclose.
Philip Van Damme	The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for QurAlis. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for VectorY. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NRG Therapeutics. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van Damme has received research support from CSL Behring.
Supurna Ghosh, PhD	Dr. Ghosh has received personal compensation for serving as an employee of Revalesio Corporation.
Janet Benesh, BSMT	No disclosure on file
Jayson D. Rodriguez, MD	No disclosure on file
Elias S. Sotirchos, MD	Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Sotirchos has received research support from National Institutes of Health. The institution of Dr. Sotirchos has received research support from National Multiple Sclerosis Society. The institution of Dr. Sotirchos has received research support from Sumaira Foundation. The institution of Dr. Sotirchos has received research support from Genentech. The institution of Dr. Sotirchos has received research support from UCB. The institution of Dr. Sotirchos has received research support from Astoria Biologica. The institution of Dr. Sotirchos has received research support from Ad Scientiam. The institution of Dr. Sotirchos has received research support from Alexion. The institution of Dr. Sotirchos has received research support from Corevitas. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Ad Hoc Reviewer with National Institutes of Health.
Thomas Dehmel	No disclosure on file
Chamindra G. Laverty, MD	The institution of Dr. Laverty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta . Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Laverty has received research support from Sarepta. The institution of Dr. Laverty has received research support from Novartis Gene Therapies. The institution of Dr. Laverty has received research support from Italfarmaco. The institution of Dr. Laverty has received research support from Fibrogen. The institution of Dr. Laverty has received research support from Avidity. The institution of Dr. Laverty has received research support from Dyne.
Ahmad R. Abuzinadah, MBBS	No disclosure on file
Shiv Saidha, MD	Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Setpoint Medical. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis.
Virginia Sturm, PhD	Dr. Sturm has nothing to disclose.
Clemens Warnke	The institution of Clemens Warnke has received research support from Novartis. The institution of Clemens Warnke has received research support from Alexion. The institution of Clemens Warnke has received research support from Sanofi-Genzyme. The institution of Clemens Warnke has received research support from Biogen. The institution of Clemens Warnke has received research support from Roche.
Dieter Haering	Dieter Haering has received personal compensation for serving as an employee of Novartis.
Laura M. Seynaeve, MD	No disclosure on file
Andre Y. Son	No disclosure on file
Sarita W. Maturu, MD	Dr. Maturu has nothing to disclose.
Bernard P. Chan, MD	The institution of Dr. Chan has received research support from National University Hospital, Singapore.
Jigar P. Mankad, MD	Dr. Mankad has nothing to disclose.
Langan Ruth-Anne	No disclosure on file
Karl Deisseroth, MD	No disclosure on file
Delaram Safarpour, MD, MSCE, FAAN	Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Safarpour has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Safarpour has received research support from Medtronic. The institution of Dr. Safarpour has received research support from Amneal. The institution of Dr. Safarpour has received research support from CND life science.
Mayank Patel	No disclosure on file
Murat Kurtuncu, MD	Dr. Kurtuncu has nothing to disclose.
Adam Witt, MD	No disclosure on file
Khalida Liaquat	No disclosure on file
Luis Querol, MD, PhD	Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avilar. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocryst. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KPL. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lycia. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Querol has received research support from GBS-CIDP Foundation International. The institution of Dr. Querol has received research support from Grifols. The institution of Dr. Querol has received research support from ISCIII. The institution of Dr. Querol has received research support from CIBERER. The institution of Dr. Querol has received research support from UCB. The institution of Dr. Querol has received research support from ArgenX.
Ning S. Yang, MD	Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Yang has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Yang has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Shailesh Darji, MD	No disclosure on file
Helle Hvilsted Nielsen, MD, PhD	No disclosure on file
Krzysztof W. Selmaj	Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Sean Selva	Sean Selva has nothing to disclose.
Balakrishnan Shankar, Jr., MD	Dr. Shankar has nothing to disclose.
Yi Shiau Ng	No disclosure on file
Fatma Yesim Parman, MD	Dr. Parman has nothing to disclose.
Michael Sweeney, MD	Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Wataru Hagiwara	No disclosure on file
Jennifer A. Roggenbuck, MS, CGC	The institution of Ms. Roggenbuck has received research support from Packard Foundation.
Grainne Gorman	No disclosure on file
Arne Lauer, MD	No disclosure on file
Felix L. Nunez-Santana, PhD	No disclosure on file
Mario R. Cornejo Olivas, MD	Dr. Cornejo Olivas has received research support from UNIVERSIDAD CIENTIFICA DEL SUR. The institution of Dr. Cornejo Olivas has received research support from CHDI. The institution of Dr. Cornejo Olivas has received research support from NIH. The institution of Dr. Cornejo Olivas has received research support from GP2/ASAP/MJFF. Dr. Cornejo Olivas has a non-compensated relationship as a Secretary elect with MDS-PAS that is relevant to AAN interests or activities.
Patrizia Sola	Patrizia Sola has nothing to disclose.
Julie J. Miller, MD, PhD	Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for npj Precision Oncology. The institution of Dr. Miller has received research support from NINDS. The institution of Dr. Miller has received research support from American Cancer Society - IRG Pilot Grant. The institution of Dr. Miller has received research support from Karyopharm. The institution of Dr. Miller has received research support from NCI. The institution of Dr. Miller has received research support from American Brain Tumor Association.
Matsanga L. Kaseka, MD	No disclosure on file
Amy Guo	No disclosure on file
Teodora Cartisano, MD	No disclosure on file
Guangwei Du, MD, PhD	No disclosure on file
Christopher T. Doughty, MD	Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurometrix. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Doughty has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TD Securities. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Adler¦Cohen¦Harvey¦Wakeman¦Guekguezian, LLP. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gidley, Sarli & Marusak, LLP. Dr. Doughty has received research support from NINDS/NeuroNEXT. Dr. Doughty has received research support from AstraZeneca. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a Grant Advisory Board Member with Dysimmune Diseases Foundation. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a CME Lecturer with Oakstone Publishing.
Nazli Basak	No disclosure on file
Kylie Ternes, MD	No disclosure on file
Eliana Vasquez	Ms. Vasquez has nothing to disclose.
Takahiro Kuwashiro	No disclosure on file
Syndi Seinfeld, DO, FAAN	No disclosure on file
Sammy D. Pishanidar, MD	No disclosure on file
Jason R. Thonhoff, MD	Dr. Thonhoff has nothing to disclose.
Liliana B. Patrucco, MD	Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Michelle Demos, MD	No disclosure on file
Byung-Ok Choi, MD, PhD	No disclosure on file
Shu-Ching Hu, MD	No disclosure on file
Katherine P. Rankin, PhD	The institution of Dr. Rankin has received research support from Marcus Foundation.
Marinella Clerico, MD	Dr. Clerico has nothing to disclose.
Craig S. Moore, PhD	Dr. Moore has nothing to disclose.
Dong-Hui Chen, MD, PhD	No disclosure on file
Mikio Shoji, MD	No disclosure on file
Asako Takanohashi, PhD, DVM	Dr. Takanohashi has nothing to disclose.
Barbara L. Nye, MD	Dr. Nye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biohaven. Dr. Nye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for upsher smith. Dr. Nye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for impel. Dr. Nye has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England.
Marijean Buhse	Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Elizabeth Nowak	No disclosure on file
Jessica A. Sagen, MA	Ms. Sagen has nothing to disclose.
Brian Appleby, MD	Dr. Appleby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Appleby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis. Dr. Appleby has received personal compensation in the range of $0-$499 for serving as a Consultant for Sangamo. The institution of Dr. Appleby has received research support from CJD Foundation. The institution of Dr. Appleby has received research support from Ionis. The institution of Dr. Appleby has received research support from Alector. The institution of Dr. Appleby has received research support from CDC. The institution of Dr. Appleby has received research support from NIH. Dr. Appleby has received publishing royalties from a publication relating to health care. Dr. Appleby has received publishing royalties from a publication relating to health care.
S. T. Carmichael, MD, PhD	Dr. Carmichael has received personal compensation in the range of $0-$499 for serving as a Consultant for BlueRock Therapeutics LP. Dr. Carmichael has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrobiologics. The institution of Dr. Carmichael has received research support from Calico Labs. The institution of Dr. Carmichael has received research support from BrainQ. Dr. Carmichael has received publishing royalties from a publication relating to health care.
Urvi G. Desai, MD, FAAN	Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Wei-Feng Luo	No disclosure on file
Laura M. Scorr, MD	Dr. Scorr has received research support from Dystonia Medical Research Foundation.
Brian L. Appavu, MD	Dr. Appavu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natus. The institution of Dr. Appavu has received research support from American Heart Association. The institution of Dr. Appavu has received research support from United States Department of Defense.
Hossam A. Shaltout, PhD	Dr. Shaltout has nothing to disclose.
Seung-Hun Oh, MD	No disclosure on file
Sasha Gupta, MD	Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend . Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Eva Martinez-Caceres	No disclosure on file
Matthew Schrag, MD	No disclosure on file
Christina DiVincenzo	No disclosure on file
Kevin R. Blauth, PhD	No disclosure on file
Philippine Dana Peralta, MD	No disclosure on file
Colleen Wahl	No disclosure on file
Rainald Schmidt-Kastner	No disclosure on file
Leila Jackson	No disclosure on file
Tuyen Ong	No disclosure on file
Gerardo Iuliano, PhD	Dr. Iuliano has nothing to disclose.
Mohammed A. ElSherif, MD, PhD, FAAN	Dr. ElSherif has nothing to disclose.
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Felipe Von Glehn Silva, MD, PhD, MSc, FAAN	Dr. Von Glehn Silva has nothing to disclose.
Claudia Z. Chou, MD	Dr. Chou has nothing to disclose.
Cavit Boz, MD	Dr. Boz has nothing to disclose.
Dianalee McKnight, PhD	Dr. McKnight has nothing to disclose.
Brian M. Sweis	No disclosure on file
Tobias Ruck	No disclosure on file
Christoph Mayer	No disclosure on file
Adam Russak	No disclosure on file
Connor Hawkins	No disclosure on file
Raymond Hupperts	No disclosure on file
Michael Girouard	No disclosure on file
Venugopalan Y. Vishnu, MD	The institution of Dr. Vishnu has received research support from Department of Health Research.
Neha Khade, MD	No disclosure on file
Jessie Huang	No disclosure on file
Chiara Zecca, MD	Prof. Zecca has nothing to disclose.
Shiney Koshy, MD	No disclosure on file
Nadav Bleich Kimelman	Nadav Bleich Kimelman has nothing to disclose.
Ying Yang	No disclosure on file
Lars Komorowski	Lars Komorowski has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for EUROIMMUN . Lars Komorowski has stock in Revvity. Lars Komorowski has received intellectual property interests from a discovery or technology relating to health care.
Freddy Alfaro-Martinez, MD	No disclosure on file
Seyed Aidin Sajedi	No disclosure on file
Luke Whitmire, PhD	No disclosure on file
Ahmed Eldokla	No disclosure on file
Mohammed Elkider, MBBS	No disclosure on file
Laura Jardim	No disclosure on file
Catherine Ashton, MBBS	Dr. Ashton has nothing to disclose.
Uwe Zettl	Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Zettl has received research support from BMBF(Government).
Erin Robertson-Dick	No disclosure on file
Paschalis Devranis	No disclosure on file
Jeffrey Jian	No disclosure on file
Nicole Wolf	Nicole Wolf has stock in Aer Beatha. Nicole Wolf has received intellectual property interests from a discovery or technology relating to health care.
Mario Giraldo Velasquez	No disclosure on file
Serena Thompson, MD, PhD	Dr. Thompson has nothing to disclose.
Kalliopi Pitarokoili, MD	Dr. Pitarokoili has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring.
Amanda S. Lindy, PhD	Dr. Lindy has received personal compensation for serving as an employee of GeneDx.
Santina Cutrupi	No disclosure on file
Maria-Luiza Saraiva-Pereira	No disclosure on file
Sara T. Ali, MD	Dr. Ali has nothing to disclose.
Shubir Dutt	Mr. Dutt has nothing to disclose.
Janessa Manning	No disclosure on file
Liyan Li	No disclosure on file
Ana Cristina W. Dos Santos	No disclosure on file
Clifton Lewis, DO	Dr. Lewis has nothing to disclose.
Diviya Kaul, MD	Dr. Kaul has nothing to disclose.
Sanjay Anandaram, MD	Dr. Anandaram has nothing to disclose.
Fabio Nascimento, MD	Dr. Nascimento has received publishing royalties from a publication relating to health care.
Johanna Breuer	No disclosure on file
Katherine Grosset	No disclosure on file
Steve Gorny	No disclosure on file
Yuichi Iwaki	No disclosure on file
Sung Lee	No disclosure on file
Danah T. Aljaafari, MD	No disclosure on file
Natalie M. Guido-Estrada, MD	No disclosure on file
Malgorzata Jaremko, PhD	No disclosure on file
Alfonso Alejandra	No disclosure on file
Sami Fam	Sami Fam has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Sami Fam has or had stock in Astra Zeneca.
Marco Pisa, MD	Dr. Pisa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Vijay Sharma	No disclosure on file
Julia E. Staisch, MD	Dr. Staisch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Staisch has received research support from Michael J Fox.
Sarita Said-Said, MD, FAAN	Dr. Said-Said has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Gritman Medical Center.
Pradeep N. Selvan, MD	No disclosure on file
W. B. Burnette, MD	No disclosure on file
Hock Luen Teoh	No disclosure on file
Mirjam Korporal-Kuhnke, MD	Dr. Korporal-Kuhnke has nothing to disclose.
Tomoya Kubota	No disclosure on file
Marcos C. Fernandez Suarez, MD	No disclosure on file
Stephen Lee, MD, PhD	No disclosure on file
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Phil Lee, PhD	An immediate family member of Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. An immediate family member of Dr. Lee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Lee has received research support from NIH.
Fulton Velez	No disclosure on file
Ronald L. Thibert, DO	Dr. Thibert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Pharmaceuticals.
Evan C. Lewis, MD	No disclosure on file
Melanie Glenn, MD	No disclosure on file
Jonathan J. Ong, MD	No disclosure on file
Lawrence Hewitt, PhD	No disclosure on file
Nicholas T. Olney, MD	No disclosure on file
Karl J. Maki, MD	No disclosure on file
Yazhong Tao	No disclosure on file
Sirisha Sanamandra, MBBS	Dr. Sanamandra has nothing to disclose.
Jason J. Hassenstab	No disclosure on file
Pranav B. Joshi, MD, DNB	No disclosure on file
Marcelo Mattiazzi, MD	No disclosure on file
Neta Zach, PhD	No disclosure on file
Abhishek Lunagariya, MD	No disclosure on file
Emil K. Gustavsson	No disclosure on file
Matthew Klein	Matthew Klein has received personal compensation for serving as an employee of PTC Therapeutics. Matthew Klein has stock in PTC Therapeutics. Matthew Klein has received publishing royalties from a publication relating to health care.
Adam Aubuchon, MD	No disclosure on file
Amanda Currie, MD	Dr. Currie has nothing to disclose.
Giorgia Querin, MD	No disclosure on file
Hyun-Sik Yang, MD	Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axon advisors. The institution of Dr. Yang has received research support from National Institutes of Health. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a study section member with National Institutes of Health.
Fahad F. Albassam, MD	No disclosure on file
Pilar Maria Ferraro, PhD	No disclosure on file
Cem Kucukali	No disclosure on file
Alexander Niyazov	No disclosure on file
Michael Hecker, PhD	No disclosure on file
Bart Van Wijmeersch, MD, PhD	Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/Bristol Myers Group. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Pharmaceutics. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Prof. Van Wijmeersch has received research support from Merck. The institution of Prof. Van Wijmeersch has received research support from Roche.
Jose A. Cabrejo Bravo, MD	No disclosure on file
Timothy J. Turner	Timothy J. Turner has received personal compensation for serving as an employee of Sanofi. Timothy J. Turner has stock in Sanofi. Timothy J. Turner has received intellectual property interests from a discovery or technology relating to health care.
Bruce Taylor	Bruce Taylor has nothing to disclose.
Jannatul Ferdous, MD	Dr. Ferdous has nothing to disclose.
Kelsey McDermott	No disclosure on file
Molly Lamb, PhD	No disclosure on file
Keli Tahara, MD	Dr. Tahara has nothing to disclose.
Thor D. Stein, MD, PhD	Dr. Stein has nothing to disclose.
Michael Bazelot, PhD	No disclosure on file
Milton Biagioni, MD	No disclosure on file
Alberto Cucca, MD	No disclosure on file
Sabrina Kuespert, PhD	No disclosure on file
Salman Farooq, MD	No disclosure on file
Anand Venkatraman, MBBS	No disclosure on file
Vasu Saini, MD	Dr. Saini has nothing to disclose.
Antonietta Gentile	No disclosure on file
Diego Centonze	Diego Centonze has nothing to disclose.
Christian Foerch	No disclosure on file
Weijun Jin, MD	Dr. Jin has nothing to disclose.
Tobias Derfuss	An immediate family member of Tobias Derfuss has received personal compensation for serving as an employee of Roche. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. The institution of Tobias Derfuss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuraxpharm. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Sharp Dome. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Roche. An immediate family member of Tobias Derfuss has stock in Novartis. An immediate family member of Tobias Derfuss has stock in Roche. The institution of Tobias Derfuss has received research support from Roche. The institution of Tobias Derfuss has received research support from Biogen. The institution of Tobias Derfuss has received research support from Alexion.
Bernd C. Kieseier, MD	Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Alissa Butts	No disclosure on file
Viviane Heide	No disclosure on file
Radhika Patel, MD	No disclosure on file
Meiko Maeda, MD, PhD	No disclosure on file
Andrei Khomenko, MD	No disclosure on file
Carol A. Hoffman, PhD, MS, CGC	No disclosure on file
Paul Smith	No disclosure on file
Peter Balicza	No disclosure on file
Myassar Zarif	Myassar Zarif has nothing to disclose.
Ines Kobor	No disclosure on file
VASILEIOS MASTORODIMOS	No disclosure on file
Natasa Dragicevic, MD, PhD	No disclosure on file
Shashank Agarwal, MD, MBBS	Dr. Agarwal has nothing to disclose.
Julia Button	No disclosure on file
Donald Grosset	Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Glasgow Memory Clinic. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE Healthcare. The institution of Donald Grosset has received research support from Parkinson's UK. Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Clinical Director Excellence Network with Parkinson's UK.
Chiseko Ikenaga, MD, PhD	Dr. Ikenaga has nothing to disclose.
Steven Xian, MD	No disclosure on file
Jared Noroozi, MD	No disclosure on file
Pawel Tacik, MD	The institution of Dr. Tacik has received research support from Merz Therapeutics, Ipsen Pharma, Anavex Life Sciences Corp. The institution of Dr. Tacik has received research support from Merz Therapeutics, Ipsen Pharma, AbbVie Germany, Boston Scientific Medical Technology, Medtronic. Dr. Tacik has received personal compensation in the range of $5,000-$9,999 for serving as a speaker with Merz Therapeutics, Ipsen Pharma.
Ruihao Wang, MD	Dr. Wang has nothing to disclose.
Omar Al-Louzi, MD	The institution of Dr. Al-Louzi has received research support from the National Multiple Sclerosis Society and American Brain Foundation. The institution of Dr. Al-Louzi has received research support from the Department of Defense.
Sara Eyal, PhD	Dr. Eyal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dexcel Pharma, Israel. Dr. Eyal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trumed. Dr. Eyal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medinet Medical. The institution of Dr. Eyal has received research support from Israel Science Foundation. The institution of Dr. Eyal has received research support from Israel Ministry of Science & Technology. Dr. Eyal has received publishing royalties from a publication relating to health care. Dr. Eyal has received personal compensation in the range of $5,000-$9,999 for serving as a Member of professional committees with Israel Ministry of Health. Dr. Eyal has a non-compensated relationship as a Treatments and Scientific Committees, contributing editor to Epilepsy Currents with AES that is relevant to AAN interests or activities. Dr. Eyal has a non-compensated relationship as a Prioritization, Climate Change Task Forces with ILAE that is relevant to AAN interests or activities. Dr. Eyal has a non-compensated relationship as a Co-Chair, member of the Executive Committee with The Israeli Chapter of the ILAE that is relevant to AAN interests or activities.
Juan C. Giugni, MD	No disclosure on file
Recai Turkoglu	Recai Turkoglu has nothing to disclose.
Gianni Soraru	No disclosure on file
Ulrike Kaunzner, MD	Dr. Kaunzner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kaunzner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medlearning.
Tim-Henrik Bruun, PhD	No disclosure on file
Arshi Naz, MD	No disclosure on file
Ajay Goenka, MD	Dr. Goenka has nothing to disclose.
Danielle E. Harlow, PhD	No disclosure on file
Melissa A. Walker, MD, PhD	Dr. Walker has received personal compensation for serving as an employee of Massachusetts General Hospital. An immediate family member of Dr. Walker has received personal compensation for serving as an employee of Morgan Stanley & Co.. An immediate family member of Dr. Walker has received stock or an ownership interest from Morgan Stanley & Co.. The institution of Dr. Walker has received research support from United Mitochondrial Disease Foundation. The institution of Dr. Walker has received research support from Child Neurology Foundation. The institution of Dr. Walker has received research support from Massachusetts General Hospital. The institution of Dr. Walker has received research support from National Institutes of Health. Dr. Walker has received personal compensation in the range of $500-$4,999 for serving as a Platform Speaker with Harvard Medical School.
Keisuke Ueda, MD	Dr. Ueda has nothing to disclose.
Leonardo Almeida	No disclosure on file
Tyler Koehn, MD	Dr. Koehn has nothing to disclose.
Rens Hanewinckel, MD, PhD	No disclosure on file
Sandrine Herbelet, DVM	No disclosure on file
Seung Min Kim	Seung Min Kim has received research support from Veterans Health Service Medical Center Research Grant.
David Cantu, PhD	Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Candice Chapouly, PhD, PharmD	No disclosure on file
Juan Fortea, MD, PhD	Dr. Fortea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Inmune. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Fortea has received research support from NIH. Dr. Fortea has received intellectual property interests from a discovery or technology relating to health care.
Russell Dale	Mr. Dale has nothing to disclose.
Hongki Song	No disclosure on file
Brandon Lucke-Wold	Mr. Lucke-Wold has nothing to disclose.
Katherine McDonell, MD	The institution of Dr. McDonell has received research support from NINDS.
Ranjithkumar Rajendran	Mr. Rajendran has nothing to disclose.
Nikolaos Patsopoulos, MD, PhD	No disclosure on file
Ricardo Osorio	No disclosure on file
James P. Rooney	No disclosure on file
Ariel Dahan	No disclosure on file
Jessica P. Lowry, PhD	No disclosure on file
Akihiro Shindo	Akihiro Shindo has nothing to disclose.
Chia-Ju Lee, MD	No disclosure on file
Joong-Seok Kim	No disclosure on file
Xiaoyang Lan, PhD	No disclosure on file
Andrew Pennell	No disclosure on file
Jiri G. Safar, MD	No disclosure on file
Andrew Cichowski, MD	No disclosure on file
Marti Juanola-Falgarona, PhD	No disclosure on file
Pascal Lafort	Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALEXION. The institution of Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARGENX. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for JOHNSON and JOHNSON. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique.
Candace B. Borders, MD	Dr. Borders has nothing to disclose.
Jerry J. Shih, MD, FAAN	Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Shih has received research support from Neurona. The institution of Dr. Shih has received research support from NCGS, Inc. Dr. Shih has a non-compensated relationship as a Test Writing Committee Member with ABPN that is relevant to AAN interests or activities.
Emilio Perucca	Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SKB Life Sciences. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharma. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN Therapeutics. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sun Pharma. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Xenon Pharma. Emilio Perucca has received publishing royalties from a publication relating to health care. Emilio Perucca has received publishing royalties from a publication relating to health care.
Adys Mendizabal, MD, MS	Dr. Mendizabal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Clinical ��ɫ�� Alliance. Dr. Mendizabal has received research support from Huntington's Disease Society of America. Dr. Mendizabal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Huntington's Disease Society of America (HDSA).
Meagan O. Bailey, MD	Dr. Bailey has nothing to disclose.
Keren Regev, MD	Dr. Regev has nothing to disclose.
Abdulaziz Alsaman	No disclosure on file
Leticia Alvarez	No disclosure on file
Nuala McNicholas, MBBS	Dr. McNicholas has nothing to disclose.
Stuart Peltz	No disclosure on file
Harshil Shah, Jr., MBBS	No disclosure on file
Robin L. Avila, PhD	Mrs. Avila has received personal compensation for serving as an employee of Biogen. Mrs. Avila has stock in Biogen.
Dongchao Shen	No disclosure on file
Achint A. Patel	No disclosure on file
Glenda Halliday	No disclosure on file
YuWu Zhao	No disclosure on file
Jennifer J. Choi, MD	No disclosure on file
Danielle Blemur	No disclosure on file
Aina Teniente-Serra	No disclosure on file
Eanna Barra Ryan	No disclosure on file
Pavan Bhargava, MD, FAAN	The institution of Dr. Bhargava has received research support from EMD Serono. The institution of Dr. Bhargava has received research support from Amylyx pharmaceuticals. The institution of Dr. Bhargava has received research support from Genentech. The institution of Dr. Bhargava has received research support from GSK.
Elinor Ben-Menachem, MD, FAAN	Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic.
Carla M. Grosmann, MD	No disclosure on file
Kishin Koh, MD, PhD	No disclosure on file
Virginija D. Karrenbauer, MD, PhD	Dr. Karrenbauer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Mindl M. Weingarten, PharmD	Dr. Weingarten has received personal compensation for serving as an employee of SK Life Science.
Jennifer C. Massey, MBBS	No disclosure on file
Stephanie Tankou, MD, PhD	No disclosure on file
Cyrus G. Escabillas, MD	No disclosure on file
Razina Aziz-Bose, MD	Dr. Aziz-Bose has nothing to disclose.
Clara Zelasky, PA	Ms. Zelasky has nothing to disclose.
Arika Hasegawa	No disclosure on file
Michael Spino, PharmD	No disclosure on file
James Crispo	No disclosure on file
Julie McDaniel, MD	Dr. McDaniel has nothing to disclose.
Pratik Kanabur	No disclosure on file
Tacie Moskowitz	No disclosure on file
Silvia Presas	Silvia Presas has nothing to disclose.
Oluf Andersen, MD	Dr. Andersen has nothing to disclose.
Jad A. Dandashi	No disclosure on file
Eric Swayze, PhD	No disclosure on file
Caitlin White	Dr. White has nothing to disclose.
Geir Braathen	No disclosure on file
Sarah E. Buerki, MD	No disclosure on file
Khondoker Alam, MD	No disclosure on file
Uri Danon	Uri Danon has received personal compensation for serving as an employee of Mapi harma.
Tracy Brandt, PhD	No disclosure on file
Mariam Ishaque	Ms. Ishaque has nothing to disclose.
Deepak K. Gupta, MBBS	The institution of Dr. Gupta has received research support from Department of Defense.
Meena Subramanyam, PhD	No disclosure on file
Natasha Rabinowitz	No disclosure on file
Stephen Wanaski, PhD	Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has or had stock in Paragon Biosciences.Dr. Wanaski has or had stock in Emalex Biosciences.
Lisa M. Shulman, MD, FAAN	The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Alexandra Carter, MD	No disclosure on file
Theodore Larson	Theodore Larson has nothing to disclose.
Roland Thijs	No disclosure on file
Byeong Su Yim	No disclosure on file
Meghan E. Murphy, NP	No disclosure on file
Greg Mytyk	No disclosure on file
Wissam G. Deeb, MD	Dr. Deeb has a non-compensated relationship as a Board member with Davis Phinney Foundation that is relevant to AAN interests or activities.
Bruce D. Trapp, PhD	Dr. Trapp has received personal compensation for serving as an employee of Renovo Neural Inc.. The institution of Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therini Bio, Inc.. Dr. Trapp has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Trapp has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Disarm Therapeutics. Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kantonsspital Aarau AG. Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for triMS.online. The institution of Dr. Trapp has received research support from Genzyme Corporation. The institution of Dr. Trapp has received research support from ALS Association. The institution of Dr. Trapp has received research support from National Institute of Neurological Disorders and Stroke.
Thomas Neylan	The institution of Thomas Neylan has received research support from National Institutes of Aging.
Madeleine Scharf	No disclosure on file
Mahmoud M. Sobh, MBBS	No disclosure on file
Christine M. Walsh, PhD	Dr. Walsh has nothing to disclose.
David L. Perez, MD, FAAN	Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley: Brain and Behavior. Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychiatric Association Publishing. The institution of Dr. Perez has received research support from NIH. The institution of Dr. Perez has received research support from Sidney R. Baer Jr. Foundation. The institution of Dr. Perez has received research support from Warren Alpert Foundation. Dr. Perez has received publishing royalties from a publication relating to health care. Dr. Perez has received publishing royalties from a publication relating to health care.
Abdullah Muhammad	No disclosure on file
Natanya S. Russek	No disclosure on file
Jack P. Antel, MD, FAAN	Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
Salam Bachour	No disclosure on file
John F. De Groot, MD	An immediate family member of Dr. De Groot has received personal compensation for serving as an employee of Ziopharm Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Deciphera Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for FivePrime Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Carthera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadmon. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Biomedical Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Taiho Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kairos Venture Investments. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Syneos Health. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Monteris. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Agios. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mundipharma Research. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GenomiCare. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Del Mar Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tocagen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioasis Technologies, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ResTORbio, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation Medicine, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novogen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Deciphera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insys Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lily. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella Clinical. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karyopharm Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiyatec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanquish Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orsenix, Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Global Services, LLC. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBL Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines, Inc.. An immediate family member of Dr. De Groot has received stock or an ownership interest from Ziopharm Oncology. An immediate family member of Dr. De Groot has received stock or an ownership interest from Gilead. The institution of Dr. De Groot has received research support from Carthera. The institution of Dr. De Groot has received research support from HaiHe Pharma. The institution of Dr. De Groot has received research support from Taiho Pharma.
Antonella Macerollo	Antonella Macerollo has nothing to disclose.
Jyh Yung Hor, MD	No disclosure on file
Cyrus Safinia	No disclosure on file
Marna McKenzie	No disclosure on file
Jose Luiz Pedroso, MD	Dr. Pedroso has nothing to disclose.
Clara Van Karnebeek	No disclosure on file
Mary Woolsey	No disclosure on file
Tatiana Plavina, PhD	No disclosure on file
Shai Rubnov	Shai Rubnov has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Mapi pharma.
Christina Lineback, MD	Dr. Lineback has nothing to disclose.
Florian Ottenlinger	No disclosure on file
Rowan Saloner, PhD	No disclosure on file
Deepti Sharma	No disclosure on file
Satish Medicetty, PhD	No disclosure on file
Antonio Orlacchio	No disclosure on file
Jin-Tai Yu	No disclosure on file
Mauricio F. Farez, MD	Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Diogo Amarante, MD	No disclosure on file
Michelle L. Sudyn	No disclosure on file
Sharon Tamir	No disclosure on file
Andra Farcas	No disclosure on file
Nina L. Beckwith	No disclosure on file
Luca Battistini, MD	No disclosure on file
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Kateryna Schwartz	No disclosure on file
Shnehal Patel, MD	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Taylor Hall	No disclosure on file
Hui Zhang, MD	No disclosure on file
Yo-ichi Takei	No disclosure on file
Joanne Trinh	Ms. Trinh has received personal compensation for serving as an employee of synlab. Ms. Trinh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for acurex.
Robert P. Lisak, MD, FAAN	Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Yael Barnett, MD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��